<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Physiol Rep</journal-id><journal-id journal-id-type="iso-abbrev">Physiol Rep</journal-id><journal-id journal-id-type="publisher-id">phy2</journal-id><journal-title-group><journal-title>Physiological Reports</journal-title></journal-title-group><issn pub-type="ppub">2051-817X</issn><issn pub-type="epub">2051-817X</issn><publisher><publisher-name>John Wiley &#x00026; Sons, Ltd</publisher-name><publisher-loc>Chichester, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26109194</article-id><article-id pub-id-type="pmc">4510637</article-id><article-id pub-id-type="doi">10.14814/phy2.12446</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Ventilatory oscillations at exercise: effects of hyperoxia, hypercapnia, and acetazolamide</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hermand</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Lhuissier</surname><given-names>Fran&#x000e7;ois J</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Larribaut</surname><given-names>Julie</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pichon</surname><given-names>Aur&#x000e9;lien</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Richalet</surname><given-names>Jean-Paul</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au2">2</xref></contrib><aff id="au1"><label>1</label><institution>Universit&#x000e9; Paris 13, Sorbonne Paris Cit&#x000e9;, Laboratoire &#x0201c;Hypoxie et poumon&#x0201d;</institution><addr-line>Bobigny, France</addr-line></aff><aff id="au2"><label>2</label><institution>Assistance Publique-H&#x000f4;pitaux de Paris, H&#x000f4;pital Avicenne, Service de Physiologie, explorations fonctionnelles et m&#x000e9;decine du sport</institution><addr-line>Bobigny, France</addr-line></aff></contrib-group><author-notes><corresp id="cor1"><bold>Correspondence</bold> Eric Hermand, Laboratoire &#x0201c;Hypoxie et poumon&#x0201d;, EA2363, 74 rue Marcel Cachin, 93017 Bobigny Cedex, France., Tel: 33148387758, Fax: 33148388924, E-mail: <email>eric.hermand17@gmail.com</email></corresp><fn><p>
<bold>Funding Information</bold> This study was supported by Legs POIX grants from the Chancellerie des Universit&#x000e9;s de Paris (B380).
</p></fn><fn><p>Clinical Trial reg. n&#x000b0;: NCT02201875.</p></fn></author-notes><pub-date pub-type="collection"><month>6</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>24</day><month>6</month><year>2015</year></pub-date><volume>3</volume><issue>6</issue><elocation-id>e12446</elocation-id><history><date date-type="received"><day>28</day><month>5</month><year>2015</year></date><date date-type="accepted"><day>02</day><month>6</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 The Authors. <italic>Physiological Reports</italic> published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Periodic breathing has been found in patients with heart failure and sleep apneas, and in healthy subjects in hypoxia, during sleep and wakefulness, at rest and, recently, at exercise. To unravel the cardiorespiratory parameters liable to modulate the amplitude and period of ventilatory oscillations, 26 healthy subjects were tested under physiological (exercise) and environmental (hypoxia, hyperoxia, hyperoxic hypercapnia) stresses, and under acetazolamide (ACZ) treatment. A fast Fourier transform spectral analysis of breath-by-breath ventilation <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu1.jpg" mimetype="image"/></inline-formula> evidenced an increase in <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu2.jpg" mimetype="image"/></inline-formula> peak power under hypercapnia (vs. normoxia and hyperoxia, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001) and a decrease under ACZ (vs. placebo, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001), whereas it was not modified in hyperoxia. <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu3.jpg" mimetype="image"/></inline-formula> period was shortened by exercise in all conditions (vs. rest, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01) and by hypercapnia (vs. normoxia, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05) but remained unchanged under ACZ (vs. placebo). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu4.jpg" mimetype="image"/></inline-formula> peak power was positively related to cardiac output (<inline-formula><inline-graphic xlink:href="phy20003-e12446-mu5.jpg" mimetype="image"/></inline-formula>) and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu6.jpg" mimetype="image"/></inline-formula> in hyperoxia (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01), in hypercapnia (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001) and under ACZ (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu7.jpg" mimetype="image"/></inline-formula> period was negatively related to <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu8.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu9.jpg" mimetype="image"/></inline-formula> in hyperoxia (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01 and <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001, respectively), in hypercapnia (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05 and <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01, respectively) and under ACZ (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05 and <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01, respectively). Total respiratory cycle time was the main factor responsible for changes in <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu10.jpg" mimetype="image"/></inline-formula> period. In conclusion, exercise, hypoxia, and hypercapnia increase ventilatory oscillations by increasing <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu11.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu12.jpg" mimetype="image"/></inline-formula>, whereas ACZ decreases ventilatory instability in part by a contrasting action on O<sub>2</sub> and CO<sub>2</sub> sensing. An intrinsic oscillator might modulate ventilation through a complex system where peripheral chemoreflex would play a key role.</p></abstract><kwd-group><kwd>Acetazolamide</kwd><kwd>exercise</kwd><kwd>hypercapnia</kwd><kwd>hyperoxia</kwd><kwd>hypoxia</kwd><kwd>periodic breathing</kwd><kwd>ventilatory oscillations</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>In most usual circumstances, human ventilation adapts to the demand of the organism around a steady-state value. However, its control is known to be challenged under various specific conditions. For example, patients suffering from chronic heart failure (CHF) or apnea syndrome (central, obstructive, or mixed) show breathing pattern marked by large oscillations with a period of around 1&#x000a0;min at rest, awake or asleep, and during exercise. Oscillations are also present in healthy subjects at high altitude during sleep (Berssenbrugge et&#x000a0;al. <xref rid="b7" ref-type="bibr">1983</xref>; Ainslie et&#x000a0;al. <xref rid="b2" ref-type="bibr">2013</xref>), in wakeful state (Waggener et&#x000a0;al. <xref rid="b59" ref-type="bibr">1984</xref>; Fan et&#x000a0;al. <xref rid="b20" ref-type="bibr">2012</xref>) and in patients suffering from chronic mountain sickness (Richalet et&#x000a0;al. <xref rid="b48" ref-type="bibr">2005</xref>). Several factors are involved in breathing instability. Reduced blood flow and exacerbated chemosensitivity are common in CHF at rest (Pinna et&#x000a0;al. <xref rid="b45" ref-type="bibr">2000</xref>) and during exercise (Agostoni <xref rid="b1" ref-type="bibr">2008</xref>; Dhakal et&#x000a0;al. <xref rid="b17" ref-type="bibr">2012</xref>). Obstructive sleep apneas (OSA) are associated with anatomical factors inducing airway obstruction and decreased central respiratory drive to genioglossus muscle during sleep (Dempsey et&#x000a0;al. <xref rid="b16" ref-type="bibr">2010</xref>). These factors may disturb the respiratory control loop and impair the ability of the system to effectively control ventilation.</p><p>In awake subjects, only one observation of ventilatory oscillations during exercise has been reported at high altitude (Garde et&#x000a0;al. <xref rid="b26" ref-type="bibr">2012</xref>). We recently described this phenomenon, with a period of around 11&#x000a0;sec, in subjects exercising in mild hypoxia (Hermand et&#x000a0;al. <xref rid="b30" ref-type="bibr">2015</xref>). The analysis of cardiorespiratory parameters has highlighted some factors that may have an impact on the period and amplitude of ventilatory oscillations: unlike CHF patients whose severity of periodic breathing is related to reduced cardiac output, the amplitude of oscillations in healthy subjects was positively correlated with cardiac output and ventilation during exercise in hypoxia, whereas their period was shorter during exercise as compared to rest (Hermand et&#x000a0;al. <xref rid="b30" ref-type="bibr">2015</xref>).</p><p>Peripheral and central chemoreceptors, respectively, inform respiratory centers about O<sub>2</sub> and CO<sub>2</sub> status. The response to hypoxia is mainly due to peripheral chemoreceptors (Lahiri et&#x000a0;al. <xref rid="b35" ref-type="bibr">2006</xref>; Kumar and Prabhakar <xref rid="b33" ref-type="bibr">2012</xref>), whereas the level of arterial or interstitial partial pressure of CO<sub>2</sub> (<sc>Pco</sc><sub>2</sub>) is detected by central chemoreceptors, with gain adjustments from peripheral chemoreceptors (Lahiri and Forster <xref rid="b34" ref-type="bibr">2003</xref>; Blain et&#x000a0;al. <xref rid="b8" ref-type="bibr">2010</xref>), although these interactions have been debated in humans (Duffin and Mateika <xref rid="b18" ref-type="bibr">2013</xref>). We suggested that peripheral chemoreceptors play an important role in the genesis of ventilatory oscillations, more pronounced in subjects with a higher hypoxic ventilatory response, thus revealing the unstable nature of the ventilatory control system under physiological and environmental stresses. The degree of ventilatory instability is linked to the loop gain, which is the product of the controller gain, that is, the ventilatory response to hypoxia and/or hypercapnia, and the plant gain, that is, the effect of a ventilation variation on arterial <sc>Pco</sc><sub>2</sub> (Pa<sc>co</sc><sub>2</sub>) and/or arterial <sc>Po</sc><sub>2</sub> (Pa<sc>o</sc><sub>2</sub>). The higher the gain, the more unstable the system (Cherniack <xref rid="b14" ref-type="bibr">2005</xref>; Burgess <xref rid="b11" ref-type="bibr">2012</xref>). Therefore, as in CHF, a greater sensitivity of central and peripheral respiratory drive to CO<sub>2</sub> and O<sub>2</sub>, through greater hypoxic and hypercapnic ventilatory responses (Solin et&#x000a0;al. <xref rid="b54" ref-type="bibr">2000</xref>; Giannoni et&#x000a0;al. <xref rid="b27" ref-type="bibr">2009</xref>; Maestri et&#x000a0;al. <xref rid="b39" ref-type="bibr">2013</xref>) would lead to more pronounced oscillations of ventilation (Francis et&#x000a0;al. <xref rid="b24" ref-type="bibr">2000</xref>; Basner <xref rid="b6" ref-type="bibr">2011</xref>).</p><p>Various interventions are available to modulate this breathing instability. Occasional CO<sub>2</sub> inhalation during sleep considerably diminishes apnea occurrences in Cheynes-Stokes respiration (CSR) by keeping CO<sub>2</sub> arterial pressure above apneic threshold (Andreas et&#x000a0;al. <xref rid="b4" ref-type="bibr">1998</xref>; Lorenzi-Filho et&#x000a0;al. <xref rid="b38" ref-type="bibr">1999</xref>). Hyperoxia has more conflicting effects: it reduces the hypoxemia involved in the mechanisms of periodic breathing, and therefore improves heart condition, physical performance, and apnea/hypopnea index in CSR patients (Andreas et&#x000a0;al. <xref rid="b3" ref-type="bibr">1996</xref>; Franklin et&#x000a0;al. <xref rid="b25" ref-type="bibr">1997</xref>), but does not abolish ventilatory oscillations in OSA (Gold et&#x000a0;al. <xref rid="b28" ref-type="bibr">1985</xref>) and CHF patients (Ponikowski et&#x000a0;al. <xref rid="b46" ref-type="bibr">1999</xref>). Conversely, at high altitude, O<sub>2</sub> therapy significantly reduces sleep apneas and periodic breathing, and improves sleep quality in normal subjects (McElroy et&#x000a0;al. <xref rid="b40" ref-type="bibr">2000</xref>; Moraga et&#x000a0;al. <xref rid="b42" ref-type="bibr">2014</xref>).</p><p>Pharmacological interventions are also available for breathing disorders. Carbonic anhydrase inhibitors are proven to be effective treatment for acute (Swenson et&#x000a0;al. <xref rid="b56" ref-type="bibr">1991</xref>) and chronic (Richalet et&#x000a0;al. <xref rid="b48" ref-type="bibr">2005</xref>) mountain sickness, as well as for ventilatory disorders in healthy subjects at high altitude (Swenson et&#x000a0;al. <xref rid="b56" ref-type="bibr">1991</xref>; Fischer et&#x000a0;al. <xref rid="b21" ref-type="bibr">2004</xref>; Ainslie et&#x000a0;al. <xref rid="b2" ref-type="bibr">2013</xref>). They are also experimentally used to treat periodic breathing in CSR, CHF, and OSA patients (Edwards et&#x000a0;al. <xref rid="b19" ref-type="bibr">2012</xref>; Apostolo et&#x000a0;al. <xref rid="b5" ref-type="bibr">2014</xref>; Javaheri et&#x000a0;al. <xref rid="b32" ref-type="bibr">2014</xref>). Their complex action is still to be fully understood, and involves several contradictory mechanisms, associating central stimulation, and reduction in peripheral chemoreceptors activity (Swenson <xref rid="b55" ref-type="bibr">1998</xref>; Teppema <xref rid="b57" ref-type="bibr">2014</xref>). Through a greater stimulation of central chemoreceptors by CO<sub>2</sub>, acetazolamide (ACZ) elevates ventilation level and O<sub>2</sub> saturation in patients suffering from apneas and in healthy subjects at high altitude, and considerably reduces occurrence and length of apnea episodes. ACZ also increases ventilatory response to CO<sub>2</sub> in patients with chronic mountain sickness (Rivera-Ch et&#x000a0;al. <xref rid="b51" ref-type="bibr">2008</xref>). A similar effect on ventilatory oscillations was observed in awake CHF patients at rest and during exercise (Fontana et&#x000a0;al. <xref rid="b22" ref-type="bibr">2011</xref>; Apostolo et&#x000a0;al. <xref rid="b5" ref-type="bibr">2014</xref>). Similarly, the role of ACZ-induced changes in controller gain and plant gain are still debated (Burgess <xref rid="b11" ref-type="bibr">2012</xref>; Edwards et&#x000a0;al. <xref rid="b19" ref-type="bibr">2012</xref>).</p><p>Until now, the phenomenon of ventilatory oscillations was well described mostly in patients and in sojourners at high altitude during sleep. Recently, a similar pattern was unveiled in normal subjects during exercise in hypoxia (Hermand et&#x000a0;al. <xref rid="b30" ref-type="bibr">2015</xref>). Since the period of oscillations observed in this preliminary study is much shorter than in patients, and as the intensity of oscillations is associated with high cardiac output (exercise) contrary to pathological conditions (CHF, CSR), this strongly suggests that the involved mechanisms are different. Therefore, the objective of this study is to unravel the mechanisms by which the ventilatory control system becomes unstable and generates oscillations in awake subjects at exercise.</p><p>In order to assess the respective role of central and peripheral chemoreceptors, respectively, sensitive to variations of CO<sub>2</sub> and O<sub>2</sub>, we propose to submit our model of ventilatory oscillations in healthy subjects to various external constraints such as hyperoxia, hypercapnia and pharmacological treatment by ACZ.</p></sec><sec sec-type="methods"><title>Subjects and Methods</title><sec><title>Subjects</title><p>Twenty-six healthy and nonsmoking male subjects volunteered for the study and were given complete information about the successive tests. All were in good physical condition, with a medium to high level of regular physical activity (from 2 to 10&#x000a0;h per week). They showed no evidence of cardiovascular or pulmonary disease. Subjects&#x02019; characteristics are presented in Table<xref ref-type="table" rid="tbl1">1</xref>. The protocol was approved by the Ile-de-France Ethics Committee (CPP-IDF2) and an individual written informed consent has been collected from all subjects. The study was registered as Clinical Trial reg. n&#x000b0;: NCT02201875.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Characteristics of the subjects of the hyperoxia/hypercapnic hyperoxia and acetazolamide (ACZ) studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">
<italic>n</italic>
</th><th align="center" rowspan="1" colspan="1">Age (years)</th><th align="center" rowspan="1" colspan="1">Body weight (kg)</th><th align="center" rowspan="1" colspan="1">Height (cm)</th><th align="center" rowspan="1" colspan="1">Maximal Aerobic Power (W)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Hyperoxia/Hypercapnic hyperoxia</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">30.0&#x000a0;&#x000b1;&#x000a0;9.3</td><td align="center" rowspan="1" colspan="1">73.7&#x000a0;&#x000b1;&#x000a0;9.0</td><td align="center" rowspan="1" colspan="1">174.7&#x000a0;&#x000b1;&#x000a0;7.8</td><td align="center" rowspan="1" colspan="1">272.7&#x000a0;&#x000b1;&#x000a0;44.2</td></tr><tr><td align="left" rowspan="1" colspan="1">ACZ</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">24.3&#x000a0;&#x000b1;&#x000a0;3.8</td><td align="center" rowspan="1" colspan="1">71.8&#x000a0;&#x000b1;&#x000a0;5.6</td><td align="center" rowspan="1" colspan="1">174.8&#x000a0;&#x000b1;&#x000a0;5.6</td><td align="center" rowspan="1" colspan="1">233.3&#x000a0;&#x000b1;&#x000a0;38.5</td></tr></tbody></table><table-wrap-foot><fn id="tf1-1"><p>Mean&#x000a0;&#x000b1;&#x000a0;SD. No significant difference between groups.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Procedure</title><p>All subjects were first asked to perform a standard ramp test protocol on a cycloergometer to determine their maximal aerobic power (MAP, Table<xref ref-type="table" rid="tbl1">1</xref>): after a 3-min warm-up at 60 watts, power output was increased by 30-watt steps every 2&#x000a0;min until exhaustion.</p><p>For all studies, minute ventilation (<inline-formula><inline-graphic xlink:href="phy20003-e12446-mu13.jpg" mimetype="image"/></inline-formula>, L.min<sup>&#x02212;1</sup>) was measured through a metabograph (Vmax Encore; SensorMedics, Yorba Linda, CA). Tidal volume (VT, L), total respiratory cycle time (Ttot, sec), and inspiratory time (Ti, sec) were derived from the ventilation signal. Pulse O<sub>2</sub> saturation (SpO<sub>2</sub>, %) was measured by transcutaneous oximetry (Nellcor N-595; Nellcor, Pleasanton, CA) on a prewarmed ear lobe. End tidal <sc>Pco</sc><sub>2</sub> (PE<sc>TCO</sc><sub>2</sub>, mmHg) was measured by infrared thermopile (Vmax Encore, SensorMedics). During the whole test, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu14.jpg" mimetype="image"/></inline-formula>, SpO<sub>2</sub> and PE<sc>TCO</sc><sub>2</sub> were recorded breath-by-breath (Fig.<xref ref-type="fig" rid="fig01">1</xref>). Data were transferred to a computer for further variability analysis. A Fast Fourier Transform (FFT) was then applied to the breath-by-breath ventilation signal, extracted from the raw data, in sequences of 128 points (one point per second) of a steady-state interval at the end of each phase of the test. This method allowed us to detect the presence of peaks in the frequency domain of the ventilation signal (Fig.<xref ref-type="fig" rid="fig02">2</xref>) (Hermand et&#x000a0;al. <xref rid="b30" ref-type="bibr">2015</xref>). Two main parameters were derived from the FFT: the frequency in hertz (or period in seconds) of the larger peak and its power estimated as the area under the peak at &#x000b1;0.02&#x000a0;Hz around the peak (in L<sup>2</sup>&#x000b7;min<sup>&#x02212;2</sup>, %<sup>2</sup> and mm&#x000b7;Hg<sup>2</sup>, respectively, for <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu15.jpg" mimetype="image"/></inline-formula>, SpO<sub>2</sub>, and PETCO<sub>2</sub> spectra). Thus, a high peak power translates into greater ventilatory oscillations. This method allowed us to precisely quantify the presence of oscillations in the signals that are not observable in the standard protocol routinely used in the hypoxic exercise test where the signals are averaged every 20&#x000a0;sec (Lhuissier et&#x000a0;al. <xref rid="b37" ref-type="bibr">2012</xref>; Richalet et&#x000a0;al. <xref rid="b49" ref-type="bibr">2012</xref>; Bourdillon et&#x000a0;al. <xref rid="b9" ref-type="bibr">2014</xref>; Canou&#x000ef;-Poitrine et&#x000a0;al. <xref rid="b12" ref-type="bibr">2014</xref>). Cardiac output (<inline-formula><inline-graphic xlink:href="phy20003-e12446-mu16.jpg" mimetype="image"/></inline-formula>, L&#x000b7;min<sup>&#x02212;1</sup>) was measured using a noninvasive impedance cardiograph device (PhysioFlow PF-05; Manatec Biomedical, Paris, France) (Charloux et&#x000a0;al. <xref rid="b13" ref-type="bibr">2000</xref>; Richard et&#x000a0;al. <xref rid="b50" ref-type="bibr">2001</xref>).</p><fig id="fig01" position="float"><label>Figure 1</label><caption><p>Breath-by-breath ventilation recordings in subject n&#x000b0; 4, under placebo (upper panel) and acetazolamide (lower panel) treatment. Inlets: ventilatory response to CO<sub>2</sub> (upper right: placebo, lower right: acetazolamide).</p></caption><graphic xlink:href="phy20003-e12446-f1"/></fig><fig id="fig02" position="float"><label>Figure 2</label><caption><p>Power spectral density of the ventilation signal at exercise. Left panel: normoxia, hyperoxia, and hypercapnic hyperoxia (subject n&#x000b0;4). Right panel: placebo and ACZ (subject n&#x000b0;4) in hypoxia.</p></caption><graphic xlink:href="phy20003-e12446-f2"/></fig><p>The ventilatory response to CO<sub>2</sub> (HCVR) was determined using a modified Read's rebreathing method (Read <xref rid="b47" ref-type="bibr">1967</xref>). After breathing room air through a mouthpiece device to establish a baseline, the valve was switched to a 10-L rebreathing bag containing a mixture of 93% O<sub>2</sub> and 7% CO<sub>2</sub>. After two deep breaths in order to speed up the gas mixing in the lungs, the subject was asked to spontaneously breathe in the bag until ventilation reached 60&#x000a0;L&#x000b7;min<sup>&#x02212;1</sup>. Collected data were then compiled in a <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu17.jpg" mimetype="image"/></inline-formula>-PETCO<sub>2</sub> graph to calculate HCVR from the slope of the linear regression between <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu18.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> (see inlets in Fig.<xref ref-type="fig" rid="fig01">1</xref>). HCVR was measured once in each subject for the hyperoxia and hypercapnic hyperoxia studies and twice (under placebo and ACZ) in the ACZ study.</p></sec><sec><title>Hyperoxia and hypercapnic hyperoxia studies</title><p>Four tests were randomly conducted, in normoxia and hyperoxia (O<sub>2</sub>&#x000a0;100%), then, at least 1&#x000a0;week apart, in normoxia and hypercapnic hyperoxia (O<sub>2</sub>&#x000a0;93%, CO<sub>2</sub> 7%) in 13 subjects. After 1&#x000a0;min rest for material habituation and cardiorespiratory parameters stabilization, subjects were first asked to keep a resting sitting position on the ergometer for 6&#x000a0;min, and then to pedal for 6&#x000a0;min at around 65&#x000a0;rpm pedaling cadence at an exercise intensity of 30% of MAP.</p></sec><sec><title>ACZ study</title><p>In a double-blind, placebo-controlled, cross-over study, 13 subjects were asked to take either a placebo or a 250&#x000a0;mg ACZ pill, on morning breakfast and at midday lunch, on the day before and on tests days. Tests were performed in the afternoon following the last intake. One week at least separated the two testing days. Under each condition, subjects underwent two randomized tests: one in normoxia and one in hypoxia (normobaric simulated altitude of 3000&#x000a0;m). As in the hypercapnic hyperoxia studies, a 6-min rest/6-min exercise test was performed and exercise intensity was set at 30% of MAP.</p><sec><title>Statistical analysis</title><p>Results are presented as mean&#x000a0;&#x000b1;&#x000a0;standard deviation. Regarding the expected difference in mean period (3&#x000a0;sec), the standard deviation (2.4&#x000a0;sec), a level of significance at 0.05% and a statistical power at 80%, the minimum number of subjects to be included was 7 for each protocol. As spectra peak power showed a high standard deviation and a non-normal distribution, we performed a logarithmic transformation of raw data, and calculated a minimum number of subjects of 10 to include. Normality of data on each condition (rest/exercise, normoxia/hypoxia/hyperoxia/hypercapnia, placebo/ACZ) were verified by a Shapiro&#x02013;Wilk normality test. In the hyperoxia and hypercapnic hyperoxia studies, two-way analyses of variance (ANOVA) with repeated measures were done (rest/exercise, normoxia/hyperoxia or normoxia/hypercapnic hyperoxia). The same subjects participated in both hyperoxic and hypercapnic hyperoxic studies. Therefore, we performed a two-way analysis of variance (rest/exercise, hyperoxia/hypercapnic hyperoxia) with repeated measures to point out the specific role of hypercapnia on cardiorespiratory parameters. In the ACZ study, a three-way analysis of variance with repeated measures was performed to evaluate the difference in period and peak power of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu19.jpg" mimetype="image"/></inline-formula>, SpO<sub>2</sub>, and PETCO<sub>2</sub> spectra between conditions (rest/exercise, normoxia/hypoxia, placebo/ACZ). A post hoc paired Student's test was then used when applicable. As exercise is associated with a concomitant variation in multiple variables, we performed a multivariate regression analysis in order to evaluate the independent influence of each cardiorespiratory variable on period and peak power of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu20.jpg" mimetype="image"/></inline-formula>, SpO<sub>2</sub>, and PETCO<sub>2</sub> spectra. This approach, for example, will allow us to assess the specific influence of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu21.jpg" mimetype="image"/></inline-formula> and/or <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu22.jpg" mimetype="image"/></inline-formula> on peak power and period of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu23.jpg" mimetype="image"/></inline-formula>.</p></sec></sec></sec><sec sec-type="results"><title>Results</title><p>Values of measured cardiorespiratory variables are presented in Table<xref ref-type="table" rid="tbl2">2</xref>.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Mean values of cardiorespiratory parameters for the hyperoxia (Hox), hypercapnic hyperoxia (Hox Hcap), and acetazolamide (ACZ) studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1"><inline-formula><inline-graphic xlink:href="phy20003-e12446-mu24.jpg" mimetype="image"/></inline-formula>(L&#x000b7;min<sup>&#x02212;1</sup>)</th><th align="center" colspan="2" rowspan="1">SpO<sub>2</sub> (%)</th><th align="center" colspan="2" rowspan="1">PE<sc>TCO</sc><sub>2</sub> (mmHg)</th><th align="center" colspan="2" rowspan="1"><inline-formula><inline-graphic xlink:href="phy20003-e12446-mu25.jpg" mimetype="image"/></inline-formula>(L&#x000b7;min<sup>&#x02212;1</sup>)</th><th align="center" colspan="2" rowspan="1">Ti (sec)</th><th align="center" colspan="2" rowspan="1">Ttot (sec)</th><th align="center" colspan="2" rowspan="1">VT (L)</th><th align="center" rowspan="1" colspan="1">HCVR (L&#x000b7;min<sup>&#x02212;1</sup> &#x000b7;mmHg<sup>&#x02212;1</sup>)</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Rest</th><th align="center" rowspan="1" colspan="1">Exer.</th><th align="center" rowspan="1" colspan="1">Rest</th><th align="center" rowspan="1" colspan="1">Exer.</th><th align="center" rowspan="1" colspan="1">Rest</th><th align="center" rowspan="1" colspan="1">Exer.</th><th align="center" rowspan="1" colspan="1">Rest</th><th align="center" rowspan="1" colspan="1">Exer.</th><th align="center" rowspan="1" colspan="1">Rest</th><th align="center" rowspan="1" colspan="1">Exer.</th><th align="center" rowspan="1" colspan="1">Rest</th><th align="center" rowspan="1" colspan="1">Exer.</th><th align="center" rowspan="1" colspan="1">Rest</th><th align="center" rowspan="1" colspan="1">Exer.</th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" colspan="16" rowspan="1"><bold>Study Hox</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Nx</td><td align="left" rowspan="1" colspan="1">11.4&#x000a0;&#x000b1;&#x000a0;1.9</td><td align="left" rowspan="1" colspan="1">33.9&#x000a0;&#x000b1;&#x000a0;4.2<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">96.2&#x000a0;&#x000b1;&#x000a0;1.2</td><td align="left" rowspan="1" colspan="1">96.0&#x000a0;&#x000b1;&#x000a0;1.4</td><td align="left" rowspan="1" colspan="1">38.7&#x000a0;&#x000b1;&#x000a0;1.7</td><td align="left" rowspan="1" colspan="1">45.8&#x000a0;&#x000b1;&#x000a0;2.3</td><td align="left" rowspan="1" colspan="1">5.53&#x000a0;&#x000b1;&#x000a0;1.07</td><td align="left" rowspan="1" colspan="1">10.33&#x000a0;&#x000b1;&#x000a0;1.81<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">1.84&#x000a0;&#x000b1;&#x000a0;0.62</td><td align="left" rowspan="1" colspan="1">1.40&#x000a0;&#x000b1;&#x000a0;0.43</td><td align="left" rowspan="1" colspan="1">5.04&#x000a0;&#x000b1;&#x000a0;1.56</td><td align="left" rowspan="1" colspan="1">3.16&#x000a0;&#x000b1;&#x000a0;0.92<xref ref-type="table-fn" rid="tf2-15">##</xref></td><td align="left" rowspan="1" colspan="1">0.92&#x000a0;&#x000b1;&#x000a0;0.20</td><td align="left" rowspan="1" colspan="1">1.74&#x000a0;&#x000b1;&#x000a0;0.41<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="5" colspan="1">2.78&#x000a0;&#x000b1;&#x000a0;0.86</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hox</td><td align="left" rowspan="1" colspan="1">12.5&#x000a0;&#x000b1;&#x000a0;2.5</td><td align="left" rowspan="1" colspan="1">32.9&#x000a0;&#x000b1;&#x000a0;4.7<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">98.0&#x000a0;&#x000b1;&#x000a0;0.8<xref ref-type="table-fn" rid="tf2-20">***</xref></td><td align="left" rowspan="1" colspan="1">98.0&#x000a0;&#x000b1;&#x000a0;0.7<xref ref-type="table-fn" rid="tf2-20">***</xref></td><td align="left" rowspan="1" colspan="1">36.8&#x000a0;&#x000b1;&#x000a0;2.1<xref ref-type="table-fn" rid="tf2-20">***</xref></td><td align="left" rowspan="1" colspan="1">45.4&#x000a0;&#x000b1;&#x000a0;3.4<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">5.34&#x000a0;&#x000b1;&#x000a0;0.79</td><td align="left" rowspan="1" colspan="1">9.78&#x000a0;&#x000b1;&#x000a0;1.42<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-18">*</xref></td><td align="left" rowspan="1" colspan="1">1.42&#x000a0;&#x000b1;&#x000a0;0.37<xref ref-type="table-fn" rid="tf2-19">**</xref></td><td align="left" rowspan="1" colspan="1">1.34&#x000a0;&#x000b1;&#x000a0;0.44</td><td align="left" rowspan="1" colspan="1">4.75&#x000a0;&#x000b1;&#x000a0;1.65</td><td align="left" rowspan="1" colspan="1">3.28&#x000a0;&#x000b1;&#x000a0;0.94<xref ref-type="table-fn" rid="tf2-15">##</xref></td><td align="left" rowspan="1" colspan="1">0.93&#x000a0;&#x000b1;&#x000a0;0.21</td><td align="left" rowspan="1" colspan="1">1.73&#x000a0;&#x000b1;&#x000a0;0.34<xref ref-type="table-fn" rid="tf2-16">###</xref></td></tr><tr><td align="left" colspan="15" rowspan="1"><bold>Study Hox Hcap</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Nx</td><td align="left" rowspan="1" colspan="1">11.9&#x000a0;&#x000b1;&#x000a0;2.0</td><td align="left" rowspan="1" colspan="1">34.2&#x000a0;&#x000b1;&#x000a0;5.6<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">96.6&#x000a0;&#x000b1;&#x000a0;1.4</td><td align="left" rowspan="1" colspan="1">96.3&#x000a0;&#x000b1;&#x000a0;1.6<xref ref-type="table-fn" rid="tf2-14">#</xref></td><td align="left" rowspan="1" colspan="1">38.9&#x000a0;&#x000b1;&#x000a0;2.2</td><td align="left" rowspan="1" colspan="1">45.7&#x000a0;&#x000b1;&#x000a0;2.7<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">5.66&#x000a0;&#x000b1;&#x000a0;1.14</td><td align="left" rowspan="1" colspan="1">10.22&#x000a0;&#x000b1;&#x000a0;1.47<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">1.75&#x000a0;&#x000b1;&#x000a0;0.51</td><td align="left" rowspan="1" colspan="1">1.39&#x000a0;&#x000b1;&#x000a0;0.43<xref ref-type="table-fn" rid="tf2-15">##</xref></td><td align="left" rowspan="1" colspan="1">4.65&#x000a0;&#x000b1;&#x000a0;1.38</td><td align="left" rowspan="1" colspan="1">3.08&#x000a0;&#x000b1;&#x000a0;0.90<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">0.90&#x000a0;&#x000b1;&#x000a0;0.24</td><td align="left" rowspan="1" colspan="1">1.70&#x000a0;&#x000b1;&#x000a0;0.38<xref ref-type="table-fn" rid="tf2-16">###</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hox Hcap</td><td align="left" rowspan="1" colspan="1">35.5&#x000a0;&#x000b1;&#x000a0;8.5<xref ref-type="table-fn" rid="tf2-20">***</xref>, <xref ref-type="table-fn" rid="tf2-24">+++</xref></td><td align="left" rowspan="1" colspan="1">72.9&#x000a0;&#x000b1;&#x000a0;13.9<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-20">***</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-24">+++</xref></td><td align="left" rowspan="1" colspan="1">97.9&#x000a0;&#x000b1;&#x000a0;0.5<xref ref-type="table-fn" rid="tf2-19">**</xref></td><td align="left" rowspan="1" colspan="1">97.9&#x000a0;&#x000b1;&#x000a0;0.5<xref ref-type="table-fn" rid="tf2-19">**</xref></td><td align="left" rowspan="1" colspan="1">55.4&#x000a0;&#x000b1;&#x000a0;2.7<xref ref-type="table-fn" rid="tf2-20">***</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-24">+++</xref></td><td align="left" rowspan="1" colspan="1">66.3&#x000a0;&#x000b1;&#x000a0;3.4<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-20">***</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-24">+++</xref></td><td align="left" rowspan="1" colspan="1">5.25&#x000a0;&#x000b1;&#x000a0;0.93</td><td align="left" rowspan="1" colspan="1">10.76&#x000a0;&#x000b1;&#x000a0;1.62<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-18">*</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-22">+</xref></td><td align="left" rowspan="1" colspan="1">1.37&#x000a0;&#x000b1;&#x000a0;0.29<xref ref-type="table-fn" rid="tf2-19">**</xref></td><td align="left" rowspan="1" colspan="1">1.04&#x000a0;&#x000b1;&#x000a0;0.23<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-20">***</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-23">++</xref></td><td align="left" rowspan="1" colspan="1">3.36&#x000a0;&#x000b1;&#x000a0;0.79<xref ref-type="table-fn" rid="tf2-20">***</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-23">++</xref></td><td align="left" rowspan="1" colspan="1">2.29&#x000a0;&#x000b1;&#x000a0;0.50<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-20">***</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-24">+++</xref></td><td align="left" rowspan="1" colspan="1">1.91&#x000a0;&#x000b1;&#x000a0;0.42<xref ref-type="table-fn" rid="tf2-20">***</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-24">+++</xref></td><td align="left" rowspan="1" colspan="1">2.59&#x000a0;&#x000b1;&#x000a0;0.37<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-20">***</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-24">+++</xref></td></tr><tr><td align="left" colspan="16" rowspan="1"><bold>Study ACZ</bold></td></tr><tr><td align="left" colspan="16" rowspan="1">&#x02003;Placebo</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Nx</td><td align="left" rowspan="1" colspan="1">11.6&#x000a0;&#x000b1;&#x000a0;1.2</td><td align="left" rowspan="1" colspan="1">31.5&#x000a0;&#x000b1;&#x000a0;4.4<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">96.3&#x000a0;&#x000b1;&#x000a0;1.6</td><td align="left" rowspan="1" colspan="1">96.1&#x000a0;&#x000b1;&#x000a0;1.3</td><td align="left" rowspan="1" colspan="1">40.5&#x000a0;&#x000b1;&#x000a0;3.1</td><td align="left" rowspan="1" colspan="1">46.9&#x000a0;&#x000b1;&#x000a0;3.1<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">6.18&#x000a0;&#x000b1;&#x000a0;1.06</td><td align="left" rowspan="1" colspan="1">11.19&#x000a0;&#x000b1;&#x000a0;1.60<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">1.88&#x000a0;&#x000b1;&#x000a0;0.81</td><td align="left" rowspan="1" colspan="1">1.54&#x000a0;&#x000b1;&#x000a0;0.54<xref ref-type="table-fn" rid="tf2-14">#</xref></td><td align="left" rowspan="1" colspan="1">4.58&#x000a0;&#x000b1;&#x000a0;1.54</td><td align="left" rowspan="1" colspan="1">3.34&#x000a0;&#x000b1;&#x000a0;0.99<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">0.87&#x000a0;&#x000b1;&#x000a0;0.28</td><td align="left" rowspan="1" colspan="1">1.71&#x000a0;&#x000b1;&#x000a0;0.38<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="2" colspan="1">2.46&#x000a0;&#x000b1;&#x000a0;0.53</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Hx</td><td align="left" rowspan="1" colspan="1">12,3&#x000a0;&#x000b1;&#x000a0;1.5</td><td align="left" rowspan="1" colspan="1">33.9&#x000a0;&#x000b1;&#x000a0;4.2<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-18">*</xref></td><td align="left" rowspan="1" colspan="1">91.8&#x000a0;&#x000b1;&#x000a0;1.9<xref ref-type="table-fn" rid="tf2-20">***</xref></td><td align="left" rowspan="1" colspan="1">86.8&#x000a0;&#x000b1;&#x000a0;1.5<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-20">***</xref></td><td align="left" rowspan="1" colspan="1">40.2&#x000a0;&#x000b1;&#x000a0;2.9</td><td align="left" rowspan="1" colspan="1">44.8&#x000a0;&#x000b1;&#x000a0;1.8<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-18">*</xref></td><td align="left" rowspan="1" colspan="1">6.93&#x000a0;&#x000b1;&#x000a0;1.17<xref ref-type="table-fn" rid="tf2-18">*</xref></td><td align="left" rowspan="1" colspan="1">12.45&#x000a0;&#x000b1;&#x000a0;2.35<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-18">*</xref></td><td align="left" rowspan="1" colspan="1">1.77&#x000a0;&#x000b1;&#x000a0;0.61</td><td align="left" rowspan="1" colspan="1">1.46&#x000a0;&#x000b1;&#x000a0;0.53</td><td align="left" rowspan="1" colspan="1">4.23&#x000a0;&#x000b1;&#x000a0;1.07</td><td align="left" rowspan="1" colspan="1">3.12&#x000a0;&#x000b1;&#x000a0;0.90<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">0.85&#x000a0;&#x000b1;&#x000a0;0.21</td><td align="left" rowspan="1" colspan="1">1.72&#x000a0;&#x000b1;&#x000a0;0.38<xref ref-type="table-fn" rid="tf2-16">###</xref></td></tr><tr><td align="left" colspan="16" rowspan="1">&#x02003;ACZ</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Nx</td><td align="left" rowspan="1" colspan="1">12.3&#x000a0;&#x000b1;&#x000a0;1.8</td><td align="left" rowspan="1" colspan="1">35.3&#x000a0;&#x000b1;&#x000a0;4.7<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-27">&#x02020;&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">96.3&#x000a0;&#x000b1;&#x000a0;1.4</td><td align="left" rowspan="1" colspan="1">96.0&#x000a0;&#x000b1;&#x000a0;1.1</td><td align="left" rowspan="1" colspan="1">34.4&#x000a0;&#x000b1;&#x000a0;3.5<xref ref-type="table-fn" rid="tf2-28">&#x02020;&#x02020;&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">40.3&#x000a0;&#x000b1;&#x000a0;4.6<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-28">&#x02020;&#x02020;&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">6.93&#x000a0;&#x000b1;&#x000a0;1.17</td><td align="left" rowspan="1" colspan="1">12.45&#x000a0;&#x000b1;&#x000a0;2.35<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">1.88&#x000a0;&#x000b1;&#x000a0;0.61</td><td align="left" rowspan="1" colspan="1">1.46&#x000a0;&#x000b1;&#x000a0;0.53<xref ref-type="table-fn" rid="tf2-14">#</xref></td><td align="left" rowspan="1" colspan="1">4.73&#x000a0;&#x000b1;&#x000a0;2.20</td><td align="left" rowspan="1" colspan="1">3.19&#x000a0;&#x000b1;&#x000a0;0.91<xref ref-type="table-fn" rid="tf2-15">##</xref></td><td align="left" rowspan="1" colspan="1">0.93&#x000a0;&#x000b1;&#x000a0;0.30</td><td align="left" rowspan="1" colspan="1">1.82&#x000a0;&#x000b1;&#x000a0;0.41<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="2" colspan="1">3.78&#x000a0;&#x000b1;&#x000a0;1.67<xref ref-type="table-fn" rid="tf2-27">&#x02020;&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Hx</td><td align="left" rowspan="1" colspan="1">12.8&#x000a0;&#x000b1;&#x000a0;1.5</td><td align="left" rowspan="1" colspan="1">36.3&#x000a0;&#x000b1;&#x000a0;5.5<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">92.5&#x000a0;&#x000b1;&#x000a0;1.3<xref ref-type="table-fn" rid="tf2-20">***</xref></td><td align="left" rowspan="1" colspan="1">88.3&#x000a0;&#x000b1;&#x000a0;2.5<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-20">***</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-26">&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">34.1&#x000a0;&#x000b1;&#x000a0;3.8<xref ref-type="table-fn" rid="tf2-28">&#x02020;&#x02020;&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">37.9&#x000a0;&#x000b1;&#x000a0;4.5<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-19">**</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-28">&#x02020;&#x02020;&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">6.52&#x000a0;&#x000b1;&#x000a0;1.42<xref ref-type="table-fn" rid="tf2-19">**</xref></td><td align="left" rowspan="1" colspan="1">12.08&#x000a0;&#x000b1;&#x000a0;2.36<xref ref-type="table-fn" rid="tf2-16">###</xref><sup>,</sup><xref ref-type="table-fn" rid="tf2-20">***</xref></td><td align="left" rowspan="1" colspan="1">1.89&#x000a0;&#x000b1;&#x000a0;0.86</td><td align="left" rowspan="1" colspan="1">1.42&#x000a0;&#x000b1;&#x000a0;0.44<xref ref-type="table-fn" rid="tf2-15">##</xref></td><td align="left" rowspan="1" colspan="1">4.64&#x000a0;&#x000b1;&#x000a0;1.58</td><td align="left" rowspan="1" colspan="1">3.19&#x000a0;&#x000b1;&#x000a0;0.82<xref ref-type="table-fn" rid="tf2-16">###</xref></td><td align="left" rowspan="1" colspan="1">0.96&#x000a0;&#x000b1;&#x000a0;0.27</td><td align="left" rowspan="1" colspan="1">1.87&#x000a0;&#x000b1;&#x000a0;0.34<xref ref-type="table-fn" rid="tf2-16">###</xref></td></tr></tbody></table><table-wrap-foot><fn id="tf2-1"><p>Nx, normoxia</p></fn><fn id="tf2-2"><p>Hx, hypoxia</p></fn><fn id="tf2-3"><p>Exer., Exercise.</p></fn><fn id="tf2-4"><p><inline-formula><inline-graphic xlink:href="phy20003-e12446-mu26.jpg" mimetype="image"/></inline-formula>, minute ventilation</p></fn><fn id="tf2-5"><p>SpO<sub>2</sub>, pulse O<sub>2</sub> saturation</p></fn><fn id="tf2-6"><p>PE<sc>TCO</sc><sub>2</sub>, end-tidal <sc>Pco</sc><sub>2</sub></p></fn><fn id="tf2-7"><p><inline-formula><inline-graphic xlink:href="phy20003-e12446-mu27.jpg" mimetype="image"/></inline-formula>, cardiac output</p></fn><fn id="tf2-8"><p>Ti, inspiration time</p></fn><fn id="tf2-9"><p>Ttot, total respiration cycle time</p></fn><fn id="tf2-10"><p>VT, tidal volume</p></fn><fn id="tf2-11"><p>HCVR, hypercapnic ventilatory response.</p></fn><fn id="tf2-12"><p>Mean&#x000a0;&#x000b1;&#x000a0;SD.</p></fn><fn id="tf2-13"><p>Exercise versus Rest:</p></fn><fn id="tf2-14"><label>#</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05</p></fn><fn id="tf2-15"><label>##</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01</p></fn><fn id="tf2-16"><label>###</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001.</p></fn><fn id="tf2-17"><p>Hypercapnic hyperoxia or hyperoxia or hypoxia versus normoxia:</p></fn><fn id="tf2-18"><label>*</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05</p></fn><fn id="tf2-19"><label>**</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01</p></fn><fn id="tf2-20"><label>***</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001.</p></fn><fn id="tf2-21"><p>Hypercapnic hyperoxia versus hyperoxia:</p></fn><fn id="tf2-22"><label>+</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05</p></fn><fn id="tf2-23"><label>++</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01</p></fn><fn id="tf2-24"><label>+++</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001.</p></fn><fn id="tf2-25"><p>ACZ versus placebo:</p></fn><fn id="tf2-26"><label>&#x02020;</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05</p></fn><fn id="tf2-27"><label>&#x02020;&#x02020;</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01</p></fn><fn id="tf2-28"><label>&#x02020;&#x02020;&#x02020;</label><p><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001.</p></fn></table-wrap-foot></table-wrap><sec><title>Effect of hyperoxia</title><sec><title>Effect of exercise versus rest</title><p>In the two-way ANOVA, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu28.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> increased with exercise (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001), SpO<sub>2</sub> being unchanged (Fig.<xref ref-type="fig" rid="fig03">3</xref>). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu29.jpg" mimetype="image"/></inline-formula> period was shorter (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001) and its peak power higher (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001). PETCO<sub>2</sub> period decreased (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001) and its peak power increased (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05). SpO<sub>2</sub> period was shorter (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001).</p><fig id="fig03" position="float"><label>Figure 3</label><caption><p>Mean (&#x000b1;SD) values of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu30.jpg" mimetype="image"/></inline-formula>, SpO<sub>2</sub>, and PETCO<sub>2</sub> and corresponding periods and peak powers in normoxia, hyperoxia, and hypercapnic hyperoxia. Exercise versus Rest: <sup>#</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05; <sup>##</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01; <sup>###</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001. Hypercapnic hyperoxia or hyperoxia versus normoxia: *<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05; **<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01; ***<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001. Hypercapnic hyperoxia versus hyperoxia: <sup>+</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05, <sup>++</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01, <sup>+++</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001.</p></caption><graphic xlink:href="phy20003-e12446-f3"/></fig></sec><sec><title>Effect of hyperoxia versus normoxia</title><p>In the two-way ANOVA, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu31.jpg" mimetype="image"/></inline-formula> was not different in hyperoxia, whereas SpO<sub>2</sub> increased (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001) and <italic>P</italic> ETCO<sub>2</sub> decreased (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu32.jpg" mimetype="image"/></inline-formula> period tended to be slightly shorter (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>0.07), as well as PETCO<sub>2</sub> period. PETCO<sub>2</sub> peak power decreased (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01).</p><p>The post hoc analysis showed that, at exercise, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu33.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> periods were shorter in hyperoxia (vs. normoxia, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu34.jpg" mimetype="image"/></inline-formula> peak power remained unchanged, whereas PETCO<sub>2</sub> peak power decreased significantly (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05).</p></sec></sec><sec><title>Effect of hypercapnic hyperoxia</title><sec><title>Effect of exercise versus rest</title><p>In the two-way ANOVA, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu35.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> increased with exercise (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001) (Fig.<xref ref-type="fig" rid="fig03">3</xref>). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu36.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> periods were shorter (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01 and <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001, respectively) and their peak power greater (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001).</p></sec><sec><title>Effect of hypercapnic hyperoxia versus normoxia</title><p>In the two-way ANOVA, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu37.jpg" mimetype="image"/></inline-formula>, SpO<sub>2</sub>, and PETCO<sub>2</sub> increased (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001) in hypercapnic hyperoxia. <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu38.jpg" mimetype="image"/></inline-formula> period was shorter and its peak power was greater (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05 and <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001, respectively). PETCO<sub>2</sub> period was shorter (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01) and its peak power was smaller (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001).</p><p>The post hoc analysis showed that, at exercise, SpO<sub>2</sub> and PETCO<sub>2</sub> periods decreased in hypercapnic hyperoxia (vs. normoxia, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu39.jpg" mimetype="image"/></inline-formula> peak power was greater (vs. normoxia, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01), whereas PETCO<sub>2</sub> peak power was lower (vs. normoxia, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01).</p></sec></sec><sec><title>Effect of hypercapnia: hypercapnic hyperoxia versus hyperoxia</title><p>A two-way ANOVA evidenced an increase in <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu40.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> in hypercapnic hyperoxia (vs. hyperoxia, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001) (Fig.<xref ref-type="fig" rid="fig03">3</xref>). As expected, SpO<sub>2</sub> was not significantly different between conditions. The period of ventilatory oscillations tended to be shorter in hypercapnic hyperoxia (vs. hyperoxia, <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>0.054). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu41.jpg" mimetype="image"/></inline-formula> peak power was greater in hypercapnic hyperoxia (vs. hyperoxia, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001). PETCO<sub>2</sub> period was not modified by hypercapnia, whereas PETCO<sub>2</sub> peak power decreased (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001).</p></sec><sec><title>Effect of ACZ</title><p>One subject had to stop the experimentation due to side effects of ACZ administration (headaches, nausea), so that 12 subjects performed the experiment (Fig.<xref ref-type="fig" rid="fig04">4</xref>).</p><fig id="fig04" position="float"><label>Figure 4</label><caption><p>Mean (&#x000b1;SD) values of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu42.jpg" mimetype="image"/></inline-formula>, SpO<sub>2</sub>, and PETCO<sub>2</sub> and corresponding periods and peak powers in normoxia (Nx) and hypoxia (Hx), under placebo or acetazolamide treatment. Exercise versus Rest: <sup>#</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05; <sup>##</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01; <sup>###</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001. Hypoxia versus normoxia: *<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05; **<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01; ***<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001. Acetazolamide versus placebo: <sup>&#x02020;</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05, <sup>&#x02020;&#x02020;</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01, <sup>&#x02020;&#x02020;&#x02020;</sup><italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001.</p></caption><graphic xlink:href="phy20003-e12446-f4"/></fig><p>Typical complete breath-by-breath recordings in hypoxia under placebo (upper panel) and ACZ (lower panel) are presented in Fig.<xref ref-type="fig" rid="fig01">1</xref>. Oscillations of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu43.jpg" mimetype="image"/></inline-formula> during exercise are clearly less noticeable under ACZ condition, which is confirmed by a lower peak power in the corresponding frequency spectrum of the ventilation signal (Fig.<xref ref-type="fig" rid="fig02">2</xref>, right).</p><sec><title>Effect of exercise versus rest</title><p>During exercise, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu44.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> increased (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001) and SpO<sub>2</sub> decreased (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu45.jpg" mimetype="image"/></inline-formula>, SpO<sub>2</sub> and PETCO<sub>2</sub> periods were shorter (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu46.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> peak powers were higher (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001 and <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01, respectively).</p></sec><sec><title>Effect of hypoxia versus normoxia</title><p>In hypoxia, SpO<sub>2</sub> and PETCO<sub>2</sub> were lower (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001 and <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01, respectively), and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu47.jpg" mimetype="image"/></inline-formula> tended to be higher (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>0.053). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu48.jpg" mimetype="image"/></inline-formula>, SpO<sub>2</sub>, and PETCO<sub>2</sub> periods were not significantly different, whereas <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu49.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> peak power increased (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001 and <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01, respectively).</p></sec><sec><title>Effect of ACZ versus placebo</title><p>ACZ increased <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu50.jpg" mimetype="image"/></inline-formula> (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01) and lowered PETCO<sub>2</sub> (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001). As expected, SpO<sub>2</sub> did not change in normoxia. When considering only hypoxic condition, ACZ increased SpO<sub>2</sub> (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05). <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu51.jpg" mimetype="image"/></inline-formula>, SpO<sub>2</sub>, and PETCO<sub>2</sub> periods were not modified. <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu52.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> peak powers were lower under ACZ (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001). For all subjects, the average period was around 12.4&#x000a0;sec at rest and significantly decreased to 10.4&#x000a0;sec at exercise (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001), without any difference between the placebo and the ACZ groups.</p></sec></sec><sec><title>Cardiorespiratory variables affecting <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu53.jpg" mimetype="image"/></inline-formula> period and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu54.jpg" mimetype="image"/></inline-formula> peak power</title><p>In a first univariate approach, regressions for <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu55.jpg" mimetype="image"/></inline-formula> period and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu56.jpg" mimetype="image"/></inline-formula> peak power, for each condition (normoxia, hyperoxia, hypercapnic hyperoxia, placebo, and ACZ), with <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu57.jpg" mimetype="image"/></inline-formula> or <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu58.jpg" mimetype="image"/></inline-formula> were assessed (Figs.<xref ref-type="fig" rid="fig05">5</xref> and <xref ref-type="fig" rid="fig06">6</xref>, respectively). In all conditions, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu59.jpg" mimetype="image"/></inline-formula> period was negatively related to <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu60.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu61.jpg" mimetype="image"/></inline-formula> (upper panels), whereas <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu62.jpg" mimetype="image"/></inline-formula> peak power was positively correlated with <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu63.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu64.jpg" mimetype="image"/></inline-formula> (lower panels). It is noticeable that ACZ administration significantly decreased (vs. placebo) the slope of the regression between <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu65.jpg" mimetype="image"/></inline-formula> peak power and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu66.jpg" mimetype="image"/></inline-formula> as well as <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu67.jpg" mimetype="image"/></inline-formula> (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05): the higher <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu68.jpg" mimetype="image"/></inline-formula> or <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu69.jpg" mimetype="image"/></inline-formula>, the greater the effect of ACZ (Figs.<xref ref-type="fig" rid="fig05">5</xref> and <xref ref-type="fig" rid="fig06">6</xref>, lower left panels). In addition, for a given level of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu70.jpg" mimetype="image"/></inline-formula>, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu71.jpg" mimetype="image"/></inline-formula> peak power was always higher in hypercapnia, the regression slopes being similar (Fig.<xref ref-type="fig" rid="fig05">5</xref>, lower right panel). HCVR was higher under ACZ (vs. placebo, <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.01, Table<xref ref-type="table" rid="tbl2">2</xref>). However, there was no significant correlation between HCVR and the corresponding <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu72.jpg" mimetype="image"/></inline-formula> peak power, under placebo and ACZ (Fig.<xref ref-type="fig" rid="fig07">7</xref>), nor between HCVR placebo-ACZ difference and the corresponding <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu73.jpg" mimetype="image"/></inline-formula> peak power placebo-ACZ difference (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>0.18). Although the linear relationship between <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu74.jpg" mimetype="image"/></inline-formula> peak power and HCVR did not reach significance, Fig.<xref ref-type="fig" rid="fig07">7</xref> clearly shows that for a given level of HCVR, ACZ decreases <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu75.jpg" mimetype="image"/></inline-formula> peak power.</p><fig id="fig05" position="float"><label>Figure 5</label><caption><p>Ventilation period (upper panels) and peak power (lower panels) as a function of cardiac output (<inline-formula><inline-graphic xlink:href="phy20003-e12446-mu76.jpg" mimetype="image"/></inline-formula>). Left panels: ACZ and placebo. Right panels: normoxia, hyperoxia, and hypercapnic hyperoxia. Rest and exercise values have been pooled in all conditions. Normoxia and hypoxia values have been pooled in the ACZ versus placebo study. Slopes are significantly different between placebo and ACZ for the <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu77.jpg" mimetype="image"/></inline-formula> peak power versus <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu78.jpg" mimetype="image"/></inline-formula> correlation (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05).</p></caption><graphic xlink:href="phy20003-e12446-f5"/></fig><fig id="fig06" position="float"><label>Figure 6</label><caption><p>Ventilation period (upper panels) and peak power (lower panels) as a function of ventilation (<inline-formula><inline-graphic xlink:href="phy20003-e12446-mu79.jpg" mimetype="image"/></inline-formula>). Left panels: ACZ and placebo. Right panels: normoxia, hyperoxia, and hypercapnic hyperoxia. Rest and exercise values have been pooled in all conditions. Normoxia and hypoxia values have been pooled in the ACZ versus placebo study. Slopes are significantly different between placebo and ACZ for the <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu80.jpg" mimetype="image"/></inline-formula> peak power versus <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu81.jpg" mimetype="image"/></inline-formula> correlation (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.05).</p></caption><graphic xlink:href="phy20003-e12446-f6"/></fig><fig id="fig07" position="float"><label>Figure 7</label><caption><p><inline-formula><inline-graphic xlink:href="phy20003-e12446-mu82.jpg" mimetype="image"/></inline-formula> peak power as a function of HCVR for each subject under placebo and ACZ (large symbols: mean values &#x000b1; SD, black dot, Placebo; white dot, ACZ). ACZ increases HCVR and reduces <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu83.jpg" mimetype="image"/></inline-formula> peak power, but these relationships do not reach significance (Placebo: <italic>r</italic>&#x000b2;&#x000a0;=&#x000a0;0.123, <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>0.26; ACZ: <italic>r</italic>&#x000b2;&#x000a0;=&#x000a0;0.273, <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>0.08). However, it is clear that ACZ blunts the effect of HCVR on ventilatory oscillations (arrow).</p></caption><graphic xlink:href="phy20003-e12446-f7"/></fig><p>As several variables, such as <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu84.jpg" mimetype="image"/></inline-formula>, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu85.jpg" mimetype="image"/></inline-formula> and Ttot, may vary simultaneously in response to exercise or environmental constraints, we performed a multivariate regression analysis to assess the specific role of each of these variables on ventilatory oscillations. When pooling all values obtained at rest and exercise, this analysis evidenced Ttot as the most significant factor explaining changes in <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu86.jpg" mimetype="image"/></inline-formula> period (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001), as illustrated in Fig.<xref ref-type="fig" rid="fig08">8</xref>. Concerning <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu87.jpg" mimetype="image"/></inline-formula> peak power, <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu88.jpg" mimetype="image"/></inline-formula> (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.001) and Ttot (<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.02), but not <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu89.jpg" mimetype="image"/></inline-formula> (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>0.094), were found as explaining variables.</p><fig id="fig08" position="float"><label>Figure 8</label><caption><p>Linear regressions between <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu90.jpg" mimetype="image"/></inline-formula> period and total respiratory cycle time (Ttot) in the ACZ study. All values (rest/exercise, normoxia/hypoxia, placebo/ACZ) have been pooled.</p></caption><graphic xlink:href="phy20003-e12446-f8"/></fig></sec><sec><title>To summarize the main results of these three studies:</title><list list-type="order"><list-item><p>
Hyperoxia reduced the period of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu91.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> oscillations and decreased PETCO<sub>2</sub> peak power at exercise.
</p></list-item><list-item><p>
Hypercapnia increased <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu92.jpg" mimetype="image"/></inline-formula> peak power and decreased <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu93.jpg" mimetype="image"/></inline-formula> period, whereas it reduced the amplitude of PETCO<sub>2</sub> oscillations.
</p></list-item><list-item><p>
ACZ blunted <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu94.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> oscillations but did not alter corresponding periods.
</p></list-item><list-item><p>
Exercise increased amplitudes and shortened periods of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu95.jpg" mimetype="image"/></inline-formula> and PETCO<sub>2</sub> oscillations in all conditions.
</p></list-item></list></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>To our knowledge, this is the first study on ventilatory oscillations performed on healthy subjects under physiological (exercise) and environmental stress (hypoxia/hyperoxia/hypercapnia) and under pharmacological challenge (ACZ). Our previous work evidenced for the first time ventilatory oscillations in hypoxia at exercise in normal subjects, and the importance of peripheral chemoreceptors in their genesis (Hermand et&#x000a0;al. <xref rid="b30" ref-type="bibr">2015</xref>). This study reveals further factors that may modulate these oscillations and proposes some mechanistic hypotheses. Hyperoxia, which silences peripheral chemoreceptors (Sinski et&#x000a0;al. <xref rid="b52" ref-type="bibr">2014</xref>), did not modify <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu96.jpg" mimetype="image"/></inline-formula> peak power and therefore <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu97.jpg" mimetype="image"/></inline-formula> oscillations in healthy subjects, in accordance with some but not all studies in patients with mixed sleep apnea (Brack et&#x000a0;al. <xref rid="b10" ref-type="bibr">2012</xref>). We evidenced a very significant increase in <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu98.jpg" mimetype="image"/></inline-formula> peak power in hypercapnia, conversely to what was found in central and obstructive apneas, where CO<sub>2</sub> inhalation drastically reduced ventilatory oscillations (Hudgel et&#x000a0;al. <xref rid="b31" ref-type="bibr">1988</xref>; Brack et&#x000a0;al. <xref rid="b10" ref-type="bibr">2012</xref>). The effect of ACZ treatment in healthy subjects in hypoxia at exercise was similar to what was observed in subjects at high altitude (Ainslie et&#x000a0;al. <xref rid="b2" ref-type="bibr">2013</xref>) and CSR-OSA patients (Lalande et&#x000a0;al. <xref rid="b36" ref-type="bibr">2009</xref>; Brack et&#x000a0;al. <xref rid="b10" ref-type="bibr">2012</xref>): average minute ventilation was augmented and PETCO<sub>2</sub> decreased, whereas ventilatory oscillations were considerably reduced at exercise in hypoxia. This confirms the blunting of loop gain by ACZ observed in OSA patients (Edwards et&#x000a0;al. <xref rid="b19" ref-type="bibr">2012</xref>). It has been reported that ACZ could impair respiratory muscle and therefore modify the breathing pattern during exercise (Gonzales and Scheuermann <xref rid="b29" ref-type="bibr">2013</xref>). However, a much lower dose of ACZ was used in this study and exercise intensity was limited to 30% of MAP. Moreover, as VT and Ti were not modified by ACZ in rest or exercise conditions (Table<xref ref-type="table" rid="tbl2">2</xref>), we therefore assume that ACZ did not impact breathing pattern.</p><sec><title>Mechanisms</title><p>These results provide new insights on mechanisms involved in ventilatory oscillations in healthy subjects (Fig.<xref ref-type="fig" rid="fig09">9</xref>). The activity of the respiratory central pattern generator could be modulated by an oscillator, the activity of which would depend on various chemical stimuli. This oscillator would promote the instability of the system. Given that this instability seems to be directly related to the intensity of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu99.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu100.jpg" mimetype="image"/></inline-formula>, it is not surprising to observe the destabilizing effect of exercise, hypoxia and hypercapnia, which are known to increase <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu101.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu102.jpg" mimetype="image"/></inline-formula>. ACZ has contrasting effects: it inhibits the effect of hypoxia (Ainslie et&#x000a0;al. <xref rid="b2" ref-type="bibr">2013</xref>) and enhances the effect of hypercapnia on ventilation (Vovk et&#x000a0;al. <xref rid="b58" ref-type="bibr">2000</xref>). In this study, ACZ also blunts the relation between ventilatory oscillations and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu103.jpg" mimetype="image"/></inline-formula> or <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu104.jpg" mimetype="image"/></inline-formula> (Figs.<xref ref-type="fig" rid="fig05">5</xref> and <xref ref-type="fig" rid="fig09">9</xref>). Hyperoxia deactivates peripheral chemoreceptors (Sinski et&#x000a0;al. <xref rid="b52" ref-type="bibr">2014</xref>), and, to our knowledge, has no action on central chemoreceptors in humans. Although hyperoxia did not significantly decrease <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu105.jpg" mimetype="image"/></inline-formula> peak power, as we could expect regarding the inhibition of peripheral chemoreceptors, there is a tendency for a decrease in <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu106.jpg" mimetype="image"/></inline-formula> and SpO<sub>2</sub> peak power at exercise and a significant decrease in PETCO<sub>2</sub> peak power. Therefore, the hyperoxia-induced inhibition of carotid bodies would not be strong enough, alone, to modulate ventilatory oscillations.</p><fig id="fig09" position="float"><label>Figure 9</label><caption><p>Schematic diagram of potential mechanisms involved in the genesis of ventilatory oscillations in normal subjects at exercise. Breathing instability is directly related to the intensity of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu107.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu108.jpg" mimetype="image"/></inline-formula>. Exercise, hypoxia and hypercapnia increase <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu109.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu110.jpg" mimetype="image"/></inline-formula>, and therefore increase ventilatory oscillations. ACZ inhibits the effect of hypoxia and enhances the effect of hypercapnia on ventilation, and blunts the relation between <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu111.jpg" mimetype="image"/></inline-formula> or <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu112.jpg" mimetype="image"/></inline-formula>, and ventilatory oscillations. The complex effects of ACZ on this regulation system are still debated (see discussion).</p></caption><graphic xlink:href="phy20003-e12446-f9"/></fig><p>CO<sub>2</sub> stimulates central chemoreceptors, but is also, in a lesser extent, a determinant factor in peripheral chemoreflex activation in hypoxia (Mohan and Duffin <xref rid="b41" ref-type="bibr">1997</xref>). Therefore, the noticeable increase in ventilatory oscillations in hypercapnia could be mainly attributed to the activation of central chemoreceptors, without completely ruling out a potential peripheral involvement of CO<sub>2</sub> in hyperoxia.</p><p>Acetazolamide stimulates central chemoreceptors but reduces peripheral chemoreceptors activity (Ainslie et&#x000a0;al. <xref rid="b2" ref-type="bibr">2013</xref>). However, its mechanisms of action have been extensively debated (Teppema <xref rid="b57" ref-type="bibr">2014</xref>). Putting the decrease in ventilatory oscillations under ACZ in perspective with the increase in these oscillations in hypoxia when peripheral chemoreceptors are stimulated, confirms that peripheral chemoreceptors play a key role in the genesis of ventilatory oscillations. It validates the hypothesis we put forward in our preliminary study showing that oscillations are enhanced in subjects with high HVR (Hermand et&#x000a0;al. <xref rid="b30" ref-type="bibr">2015</xref>). However, ventilatory oscillations are also greater under a hyperoxic hypercapnic stress, when peripheral chemoreceptors are silenced, thus implying that central chemoreceptors are also a major actor of breathing instability. This suggests that ventilatory oscillations depend on a subtle and synergic action of both central and peripheral chemoreceptors, through arterial O<sub>2</sub> and CO<sub>2</sub> pressure.</p><p>Moreover, we observed that, in hypercapnic hyperoxia, PETCO<sub>2</sub>, and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu113.jpg" mimetype="image"/></inline-formula> exhibited dichotomous oscillations properties: PETCO<sub>2</sub> peak power was paradoxically lower in hypercapnia whereas <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu114.jpg" mimetype="image"/></inline-formula> peak power was higher. CO<sub>2</sub> stores being close to saturation in hypercapnia, despite a higher ventilation to flush it out, the measured expired CO<sub>2</sub> level is then not subjected to oscillations as observed for <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu115.jpg" mimetype="image"/></inline-formula>, as a full CO<sub>2</sub> store will damp systemic CO<sub>2</sub> variations.</p><p>ACZ augments the controller gain (HCVR) but blunts the enhancing effects of controller gain on ventilatory oscillations (Fig.<xref ref-type="fig" rid="fig07">7</xref>). This paradoxical effect of ACZ, reducing ventilatory oscillations (i.e., loop gain) in spite of the rise of controller gain, means a very significant reduction of plant gain, evoked in Javaheri's work (Javaheri et&#x000a0;al. <xref rid="b32" ref-type="bibr">2014</xref>). While we were not able to determine the value of the plant gain, we nevertheless observed a noticeable decrease in PETCO<sub>2</sub> under ACZ in all conditions (Fig.<xref ref-type="fig" rid="fig04">4</xref>), therefore inducing a lower CO<sub>2</sub> reserve and a lower plant gain (White <xref rid="b60" ref-type="bibr">2005</xref>; Javaheri et&#x000a0;al. <xref rid="b32" ref-type="bibr">2014</xref>).</p><p>Mechanisms leading to reduced ventilatory oscillations under ACZ are still debated. This may involve a third arm, the mixing gain, depending, among other factors, on cerebral blood flow which might increase the CO<sub>2</sub> washout of the cerebral spinal fluid and therefore blunt ventilatory oscillations (Younes et&#x000a0;al. <xref rid="b61" ref-type="bibr">2001</xref>; Dempsey et&#x000a0;al. <xref rid="b15" ref-type="bibr">2004</xref>; Skow et&#x000a0;al. <xref rid="b53" ref-type="bibr">2014</xref>). However, both exercise (Ogoh and Ainslie <xref rid="b43" ref-type="bibr">2009</xref>) and ACZ (Okazawa et&#x000a0;al. <xref rid="b44" ref-type="bibr">2001</xref>) are known to increase cerebral blood flow but have opposite effects on breathing instability (this study).</p><p>The multivariate analysis showing that the intensity of oscillations is related to <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu116.jpg" mimetype="image"/></inline-formula> and Ttot, but insignificantly to <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu117.jpg" mimetype="image"/></inline-formula>, gives a clue to the apparent contradiction between our observations of greater ventilatory oscillations with increasing <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu118.jpg" mimetype="image"/></inline-formula> (Fig.<xref ref-type="fig" rid="fig05">5</xref>) and the current hypothesis of low <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu119.jpg" mimetype="image"/></inline-formula> induced periodic breathing in CHF patients (Agostoni <xref rid="b1" ref-type="bibr">2008</xref>).</p><p>The tight relationship between <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu120.jpg" mimetype="image"/></inline-formula> period and Ttot observed in our previous work is confirmed (Fig.<xref ref-type="fig" rid="fig08">8</xref>): <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu121.jpg" mimetype="image"/></inline-formula> period is strongly linked to the duration of the respiratory cycle, independently of other cardiorespiratory factors such as <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu122.jpg" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu123.jpg" mimetype="image"/></inline-formula>. This suggests that Ttot is a determinant factor of the intrinsic oscillator. This correlation also pointed out a theoretical limit of <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu124.jpg" mimetype="image"/></inline-formula> oscillation period: when Ttot tends toward zero (breathing frequency tending to infinity), <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu125.jpg" mimetype="image"/></inline-formula> oscillation period tends to approximately 7&#x000a0;sec. This tight relationship between <inline-formula><inline-graphic xlink:href="phy20003-e12446-mu126.jpg" mimetype="image"/></inline-formula> period and Ttot also suggests the involvement of an internal oscillator that would modulate the activity of the central pattern generator, responsible for the generation of respiratory rhythm in mammals (Forster et&#x000a0;al. <xref rid="b23" ref-type="bibr">2014</xref>).</p><p>In conclusion, these findings confirm the existence of a mechanism that modulates ventilation and induces breathing instability, especially during exercise in hypoxic and hypercapnic conditions. This instability, unraveled in healthy awake subjects after a brisk challenge, depends on a complex regulation system involving O<sub>2</sub> and CO<sub>2</sub> sensing where both peripheral (high HVR and effect of ACZ) and central (hypercapnia and tight relationship between period and Ttot) chemoreflex seem to play a key role. We expect this study to contribute to the knowledge of factors involved in sleep apneas of central and obstructive origins.</p></sec></sec><sec><title>Conflict of Interest</title><p>None declared.</p></sec></body><back><ref-list><title>References</title><ref id="b1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agostoni</surname><given-names>P</given-names></name></person-group><article-title>Mechanisms of periodic breathing during exercise in patients with chronic heart failure</article-title><source>CHEST J</source><year>2008</year><volume>133</volume><fpage>197</fpage></element-citation></ref><ref id="b2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ainslie</surname><given-names>PN</given-names></name><name><surname>Lucas</surname><given-names>SJE</given-names></name></person-group><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>KR</given-names></name></person-group><article-title>Breathing and sleep at high altitude</article-title><source>Respir. Physiol. Neurobiol</source><year>2013</year><volume>188</volume><fpage>233</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">23722066</pub-id></element-citation></ref><ref id="b3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreas</surname><given-names>S</given-names></name><name><surname>Clemens</surname><given-names>C</given-names></name><name><surname>Sandholzer</surname><given-names>H</given-names></name><name><surname>Figulla</surname><given-names>HR</given-names></name></person-group><person-group person-group-type="author"><name><surname>Kreuzer</surname><given-names>H</given-names></name></person-group><article-title>Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure</article-title><source>J. Am. Coll. Cardiol</source><year>1996</year><volume>27</volume><fpage>1486</fpage><lpage>1490</lpage><pub-id pub-id-type="pmid">8626963</pub-id></element-citation></ref><ref id="b4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreas</surname><given-names>S</given-names></name><name><surname>Weidel</surname><given-names>K</given-names></name><name><surname>Hagenah</surname><given-names>G</given-names></name></person-group><person-group person-group-type="author"><name><surname>Heindl</surname><given-names>S</given-names></name></person-group><article-title>Treatment of Cheyne-Stokes respiration with nasal oxygen and carbon dioxide</article-title><source>Eur. Respir. J</source><year>1998</year><volume>12</volume><fpage>414</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">9727794</pub-id></element-citation></ref><ref id="b5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apostolo</surname><given-names>A</given-names></name><name><surname>Agostoni</surname><given-names>P</given-names></name><name><surname>Contini</surname><given-names>M</given-names></name><name><surname>Antonioli</surname><given-names>L</given-names></name></person-group><person-group person-group-type="author"><name><surname>Swenson</surname><given-names>ER</given-names></name></person-group><article-title>Acetazolamide and inhaled carbon dioxide reduce periodic breathing during exercise in patients with chronic heart failure</article-title><source>J. Card. Fail</source><year>2014</year><comment>doi: <ext-link ext-link-type="doi" xlink:href="10.1016/j.cardfail.2014.01.007">10.1016/j.cardfail.2014.01.007</ext-link></comment></element-citation></ref><ref id="b6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basner</surname><given-names>RC</given-names></name></person-group><article-title>Loop gain: can it help close the heart failure-periodic breathing loop?</article-title><source>Am. J. Respir. Crit. Care Med</source><year>2011</year><volume>184</volume><fpage>996</fpage><lpage>997</lpage><pub-id pub-id-type="pmid">22045747</pub-id></element-citation></ref><ref id="b7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berssenbrugge</surname><given-names>A</given-names></name><name><surname>Dempsey</surname><given-names>J</given-names></name><name><surname>Iber</surname><given-names>C</given-names></name><name><surname>Skatrud</surname><given-names>J</given-names></name></person-group><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>P</given-names></name></person-group><article-title>Mechanisms of hypoxia-induced periodic breathing during sleep in humans</article-title><source>J. Physiol</source><year>1983</year><volume>343</volume><fpage>507</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">6417326</pub-id></element-citation></ref><ref id="b8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blain</surname><given-names>GM</given-names></name><name><surname>Smith</surname><given-names>CA</given-names></name><name><surname>Henderson</surname><given-names>KS</given-names></name></person-group><person-group person-group-type="author"><name><surname>Dempsey</surname><given-names>JA</given-names></name></person-group><article-title>Peripheral chemoreceptors determine the respiratory sensitivity of central chemoreceptors to CO<sub>2</sub>: peripheral-central chemoreceptor interdependence</article-title><source>J. Physiol</source><year>2010</year><volume>588</volume><fpage>2455</fpage><lpage>2471</lpage><pub-id pub-id-type="pmid">20421288</pub-id></element-citation></ref><ref id="b9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourdillon</surname><given-names>N</given-names></name><name><surname>Fan</surname><given-names>J-L</given-names></name></person-group><person-group person-group-type="author"><name><surname>Kayser</surname><given-names>B</given-names></name></person-group><article-title>Cerebral oxygenation during the Richalet hypoxia sensitivity test and cycling time-trial performance in severe hypoxia</article-title><source>Eur. J. Appl. Physiol</source><year>2014</year><volume>114</volume><fpage>1037</fpage><lpage>1048</lpage><pub-id pub-id-type="pmid">24509979</pub-id></element-citation></ref><ref id="b10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brack</surname><given-names>T</given-names></name><name><surname>Randerath</surname><given-names>W</given-names></name></person-group><person-group person-group-type="author"><name><surname>Bloch</surname><given-names>KE</given-names></name></person-group><article-title>Cheyne-Stokes respiration in patients with heart failure: prevalence, causes, consequences and treatments</article-title><source>Respiration</source><year>2012</year><volume>83</volume><fpage>165</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">22025128</pub-id></element-citation></ref><ref id="b11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>KR</given-names></name></person-group><article-title>New insights from the measurement of loop gain in obstructive sleep apnoea</article-title><source>J. Physiol</source><year>2012</year><volume>590</volume><fpage>1781</fpage><lpage>1782</lpage><pub-id pub-id-type="pmid">22532646</pub-id></element-citation></ref><ref id="b12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canou&#x000ef;-Poitrine</surname><given-names>F</given-names></name><name><surname>Veerabudun</surname><given-names>K</given-names></name><name><surname>Larmignat</surname><given-names>P</given-names></name><name><surname>Letournel</surname><given-names>M</given-names></name><name><surname>Bastuji-Garin</surname><given-names>S</given-names></name></person-group><person-group person-group-type="author"><name><surname>Richalet</surname><given-names>J-P</given-names></name></person-group><article-title>Risk prediction score for severe high altitude illness: a cohort study</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><fpage>e100642</fpage><pub-id pub-id-type="pmid">25068815</pub-id></element-citation></ref><ref id="b13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charloux</surname><given-names>A</given-names></name><name><surname>Lonsdorfer-Wolf</surname><given-names>E</given-names></name><name><surname>Richard</surname><given-names>R</given-names></name><name><surname>Lampert</surname><given-names>E</given-names></name><name><surname>Oswald-Mammosser</surname><given-names>M</given-names></name><name><surname>Mettauer</surname><given-names>B</given-names></name><etal/></person-group><article-title>A new impedance cardiograph device for the non-invasive evaluation of cardiac output at rest and during exercise: comparison with the &#x0201c;direct&#x0201d; Fick method</article-title><source>Eur. J. Appl. Physiol</source><year>2000</year><volume>82</volume><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">10958374</pub-id></element-citation></ref><ref id="b14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherniack</surname><given-names>NS</given-names></name></person-group><article-title>Mathematical models of periodic breathing and their usefulness in understanding cardiovascular and respiratory disorders</article-title><source>Exp. Physiol</source><year>2005</year><volume>91</volume><fpage>295</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">16282367</pub-id></element-citation></ref><ref id="b15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dempsey</surname><given-names>JA</given-names></name><name><surname>Smith</surname><given-names>CA</given-names></name><name><surname>Przybylowski</surname><given-names>T</given-names></name><name><surname>Chenuel</surname><given-names>B</given-names></name><name><surname>Xie</surname><given-names>A</given-names></name><name><surname>Nakayama</surname><given-names>H</given-names></name><etal/></person-group><article-title>The ventilatory responsiveness to CO(2) below eupnoea as a determinant of ventilatory stability in sleep</article-title><source>J. Physiol</source><year>2004</year><volume>560</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">15284345</pub-id></element-citation></ref><ref id="b16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dempsey</surname><given-names>JA</given-names></name><name><surname>Veasey</surname><given-names>SC</given-names></name><name><surname>Morgan</surname><given-names>BJ</given-names></name></person-group><person-group person-group-type="author"><name><surname>O'Donnell</surname><given-names>CP</given-names></name></person-group><article-title>Pathophysiology of sleep apnea</article-title><source>Physiol. Rev</source><year>2010</year><volume>90</volume><fpage>47</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">20086074</pub-id></element-citation></ref><ref id="b17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhakal</surname><given-names>BP</given-names></name><name><surname>Murphy</surname><given-names>RM</given-names></name></person-group><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>GD</given-names></name></person-group><article-title>Exercise oscillatory ventilation in heart failure</article-title><source>Trends Cardiovasc. Med</source><year>2012</year><volume>22</volume><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">23062973</pub-id></element-citation></ref><ref id="b18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffin</surname><given-names>J</given-names></name></person-group><person-group person-group-type="author"><name><surname>Mateika</surname><given-names>JH</given-names></name></person-group><article-title>Cross-Talk opposing view: peripheral and central chemoreflexes have additive effects on ventilation in humans</article-title><source>J. Physiol</source><year>2013</year><volume>591</volume><fpage>4351</fpage><lpage>4353</lpage><pub-id pub-id-type="pmid">24037126</pub-id></element-citation></ref><ref id="b19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>BA</given-names></name><name><surname>Sands</surname><given-names>SA</given-names></name><name><surname>Eckert</surname><given-names>DJ</given-names></name><name><surname>White</surname><given-names>DP</given-names></name><name><surname>Butler</surname><given-names>JP</given-names></name><name><surname>Owens</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea</article-title><source>J. Physiol</source><year>2012</year><volume>590</volume><fpage>1199</fpage><lpage>1211</lpage><pub-id pub-id-type="pmid">22219335</pub-id></element-citation></ref><ref id="b20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>J-L</given-names></name><name><surname>Burgess</surname><given-names>KR</given-names></name><name><surname>Thomas</surname><given-names>KN</given-names></name><name><surname>Lucas</surname><given-names>SJE</given-names></name><name><surname>Cotter</surname><given-names>JD</given-names></name><name><surname>Kayser</surname><given-names>B</given-names></name><etal/></person-group><article-title>Effects of acetazolamide on cerebrovascular function and breathing stability at 5,050&#x000a0;m</article-title><source>J. Physiol</source><year>2012</year><volume>590</volume><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="pmid">22219343</pub-id></element-citation></ref><ref id="b21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>R</given-names></name><name><surname>Lang</surname><given-names>SM</given-names></name><name><surname>Leitl</surname><given-names>M</given-names></name><name><surname>Thiere</surname><given-names>M</given-names></name><name><surname>Steiner</surname><given-names>U</given-names></name></person-group><person-group person-group-type="author"><name><surname>Huber</surname><given-names>RM</given-names></name></person-group><article-title>Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude</article-title><source>Eur. Respir. J</source><year>2004</year><volume>23</volume><fpage>47</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">14738230</pub-id></element-citation></ref><ref id="b22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>M</given-names></name><name><surname>Emdin</surname><given-names>M</given-names></name><name><surname>Giannoni</surname><given-names>A</given-names></name><name><surname>Iudice</surname><given-names>G</given-names></name><name><surname>Baruah</surname><given-names>R</given-names></name></person-group><person-group person-group-type="author"><name><surname>Passino</surname><given-names>C</given-names></name></person-group><article-title>Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure</article-title><source>Am. J. Cardiol</source><year>2011</year><volume>107</volume><fpage>1675</fpage><lpage>1680</lpage><pub-id pub-id-type="pmid">21420051</pub-id></element-citation></ref><ref id="b23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forster</surname><given-names>H</given-names></name><name><surname>Bonis</surname><given-names>J</given-names></name><name><surname>Krause</surname><given-names>K</given-names></name><name><surname>Wenninger</surname><given-names>J</given-names></name><name><surname>Neumueller</surname><given-names>S</given-names></name><name><surname>Hodges</surname><given-names>M</given-names></name><etal/></person-group><article-title>Contributions of the pre-B&#x000f6;tzinger complex and the K&#x000f6;lliker-fuse nuclei to respiratory rhythm and pattern generation in awake and sleeping goats</article-title><source>Prog. Brain Res</source><year>2014</year><volume>209</volume><fpage>73</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">24746044</pub-id></element-citation></ref><ref id="b24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>DP</given-names></name><name><surname>Willson</surname><given-names>K</given-names></name><name><surname>Davies</surname><given-names>LC</given-names></name><name><surname>Coats</surname><given-names>AJ</given-names></name></person-group><person-group person-group-type="author"><name><surname>Piepoli</surname><given-names>M</given-names></name></person-group><article-title>Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications</article-title><source>Circulation</source><year>2000</year><volume>102</volume><fpage>2214</fpage><lpage>2221</lpage><pub-id pub-id-type="pmid">11056095</pub-id></element-citation></ref><ref id="b25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>KA</given-names></name><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Sahlin</surname><given-names>C</given-names></name></person-group><person-group person-group-type="author"><name><surname>Lundgren</surname><given-names>R</given-names></name></person-group><article-title>Reversal of central sleep apnea with oxygen</article-title><source>Chest</source><year>1997</year><volume>111</volume><fpage>163</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">8996011</pub-id></element-citation></ref><ref id="b26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garde</surname><given-names>A</given-names></name><name><surname>Giraldo</surname><given-names>BF</given-names></name><name><surname>Jane</surname><given-names>R</given-names></name><name><surname>Latshang</surname><given-names>TD</given-names></name><name><surname>Turk</surname><given-names>AJ</given-names></name><name><surname>Hess</surname><given-names>T</given-names></name><etal/></person-group><article-title>Periodic breathing during ascent to extreme altitude quantified by spectral analysis of the respiratory volume signal</article-title><source>Conf. Proc. IEEE Eng. Med. Biol. Soc</source><year>2012</year><volume>2012</volume><fpage>707</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">23365990</pub-id></element-citation></ref><ref id="b27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannoni</surname><given-names>A</given-names></name><name><surname>Emdin</surname><given-names>M</given-names></name><name><surname>Bramanti</surname><given-names>F</given-names></name><name><surname>Iudice</surname><given-names>G</given-names></name><name><surname>Francis</surname><given-names>DP</given-names></name><name><surname>Barsotti</surname><given-names>A</given-names></name><etal/></person-group><article-title>Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure</article-title><source>J. Am. Coll. Cardiol</source><year>2009</year><volume>53</volume><fpage>1975</fpage><lpage>1980</lpage><pub-id pub-id-type="pmid">19460611</pub-id></element-citation></ref><ref id="b28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>AR</given-names></name><name><surname>Bleecker</surname><given-names>ER</given-names></name></person-group><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PL</given-names></name></person-group><article-title>A shift from central and mixed sleep apnea to obstructive sleep apnea resulting from low-flow oxygen</article-title><source>Am. Rev. Respir. Dis</source><year>1985</year><volume>132</volume><fpage>220</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">4026046</pub-id></element-citation></ref><ref id="b29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzales</surname><given-names>JU</given-names></name></person-group><person-group person-group-type="author"><name><surname>Scheuermann</surname><given-names>BW</given-names></name></person-group><article-title>Effect of acetazolamide on respiratory muscle fatigue in humans</article-title><source>Respir. Physiol. Neurobiol</source><year>2013</year><volume>185</volume><fpage>386</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">23017330</pub-id></element-citation></ref><ref id="b30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermand</surname><given-names>E</given-names></name><name><surname>Pichon</surname><given-names>A</given-names></name><name><surname>Lhuissier</surname><given-names>FJ</given-names></name></person-group><person-group person-group-type="author"><name><surname>Richalet</surname><given-names>J-P</given-names></name></person-group><article-title>Periodic breathing in healthy humans at exercise in hypoxia</article-title><source>J. Appl. Physiol</source><year>2015</year><volume>118</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">25554800</pub-id></element-citation></ref><ref id="b31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudgel</surname><given-names>DW</given-names></name><name><surname>Hendricks</surname><given-names>C</given-names></name></person-group><person-group person-group-type="author"><name><surname>Dadley</surname><given-names>A</given-names></name></person-group><article-title>Alteration in obstructive apnea pattern induced by changes in oxygen- and carbon-dioxide-inspired concentrations</article-title><source>Am. Rev. Respir. Dis</source><year>1988</year><volume>138</volume><fpage>16</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">3144203</pub-id></element-citation></ref><ref id="b32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javaheri</surname><given-names>S</given-names></name><name><surname>Sands</surname><given-names>SA</given-names></name></person-group><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>BA</given-names></name></person-group><article-title>Acetazolamide attenuates hunter-cheyne-stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure</article-title><source>Ann. Am. Thorac. Soc</source><year>2014</year><volume>11</volume><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">24251826</pub-id></element-citation></ref><ref id="b33"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Terjung</surname><given-names>R</given-names></name></person-group><person-group person-group-type="author"><name><surname>Prabhakar</surname><given-names>NR</given-names></name></person-group><article-title>Peripheral chemoreceptors: function and plasticity of the carotid body</article-title><source>Comprehensive physiology</source><year>2012</year><publisher-loc>Hoboken, NJ, USA</publisher-loc><publisher-name>John Wiley &#x00026; Sons, Inc</publisher-name><comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://doi.wiley.com/10.1002/cphy.c100069">http://doi.wiley.com/10.1002/cphy.c100069</ext-link> [Accessed March 31, 2014]</comment></element-citation></ref><ref id="b34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahiri</surname><given-names>S</given-names></name><name><surname>Forster</surname><given-names>RE</given-names><suffix>2nd</suffix></name></person-group><article-title>CO<sub>2</sub>/H(+) sensing: peripheral and central chemoreception</article-title><source>Int. J. Biochem. Cell Biol</source><year>2003</year><volume>35</volume><fpage>1413</fpage><lpage>1435</lpage><pub-id pub-id-type="pmid">12818238</pub-id></element-citation></ref><ref id="b35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahiri</surname><given-names>S</given-names></name><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Baby</surname><given-names>SM</given-names></name><name><surname>Hoshi</surname><given-names>T</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name></person-group><person-group person-group-type="author"><name><surname>Prabhakar</surname><given-names>NR</given-names></name></person-group><article-title>Oxygen sensing in the body</article-title><source>Prog. Biophys. Mol. Biol</source><year>2006</year><volume>91</volume><fpage>249</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">16137743</pub-id></element-citation></ref><ref id="b36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalande</surname><given-names>S</given-names></name><name><surname>Snyder</surname><given-names>EM</given-names></name><name><surname>Olson</surname><given-names>TP</given-names></name><name><surname>Hulsebus</surname><given-names>ML</given-names></name><name><surname>Orban</surname><given-names>M</given-names></name><name><surname>Somers</surname><given-names>VK</given-names></name><etal/></person-group><article-title>The effects of sildenafil and acetazolamide on breathing efficiency and ventilatory control during hypoxic exercise</article-title><source>Eur. J. Appl. Physiol</source><year>2009</year><volume>106</volume><fpage>509</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">19337745</pub-id></element-citation></ref><ref id="b37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lhuissier</surname><given-names>FJ</given-names></name><name><surname>Brumm</surname><given-names>M</given-names></name><name><surname>Ramier</surname><given-names>D</given-names></name></person-group><person-group person-group-type="author"><name><surname>Richalet</surname><given-names>J-P</given-names></name></person-group><article-title>Ventilatory and cardiac responses to hypoxia at submaximal exercise are independent of altitude and exercise intensity</article-title><source>J. Appl. Physiol</source><year>2012</year><volume>112</volume><fpage>566</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">22194322</pub-id></element-citation></ref><ref id="b38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzi-Filho</surname><given-names>G</given-names></name><name><surname>Rankin</surname><given-names>F</given-names></name><name><surname>Bies</surname><given-names>I</given-names></name></person-group><person-group person-group-type="author"><name><surname>Douglas Bradley</surname><given-names>T</given-names></name></person-group><article-title>Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure</article-title><source>Am. J. Respir. Crit. Care Med</source><year>1999</year><volume>159</volume><fpage>1490</fpage><lpage>1498</lpage><pub-id pub-id-type="pmid">10228116</pub-id></element-citation></ref><ref id="b39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maestri</surname><given-names>R</given-names></name><name><surname>Bruschi</surname><given-names>C</given-names></name><name><surname>Olmetti</surname><given-names>F</given-names></name><name><surname>La Rovere</surname><given-names>MT</given-names></name></person-group><person-group person-group-type="author"><name><surname>Pinna</surname><given-names>GD</given-names></name></person-group><article-title>Assessment of the peripheral ventilatory response to CO<sub>2</sub> in heart failure patients: reliability of the single-breath test</article-title><source>Physiol. Meas</source><year>2013</year><volume>34</volume><fpage>1123</fpage><lpage>1132</lpage><pub-id pub-id-type="pmid">23969511</pub-id></element-citation></ref><ref id="b40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McElroy</surname><given-names>MK</given-names></name><name><surname>Gerard</surname><given-names>A</given-names></name><name><surname>Powell</surname><given-names>FL</given-names></name><name><surname>Prisk</surname><given-names>GK</given-names></name><name><surname>Sentse</surname><given-names>N</given-names></name><name><surname>Holverda</surname><given-names>S</given-names></name><etal/></person-group><article-title>Nocturnal O2 enrichment of room air at high altitude increases daytime O2 saturation without changing control of ventilation</article-title><source>High Alt. Med. Biol</source><year>2000</year><volume>1</volume><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">11254229</pub-id></element-citation></ref><ref id="b41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>R</given-names></name></person-group><person-group person-group-type="author"><name><surname>Duffin</surname><given-names>J</given-names></name></person-group><article-title>The effect of hypoxia on the ventilatory response to carbon dioxide in man</article-title><source>Respir. Physiol</source><year>1997</year><volume>108</volume><fpage>101</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">9232684</pub-id></element-citation></ref><ref id="b42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moraga</surname><given-names>FA</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>D</given-names></name><name><surname>Richalet</surname><given-names>JP</given-names></name><name><surname>Vargas</surname><given-names>M</given-names></name></person-group><person-group person-group-type="author"><name><surname>Osorio</surname><given-names>J</given-names></name></person-group><article-title>Periodic breathing and oxygen supplementation in Chilean miners at high altitude (4200&#x000a0;m)</article-title><source>Respir. Physiol. Neurobiol</source><year>2014</year><volume>203</volume><fpage>109</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">25219448</pub-id></element-citation></ref><ref id="b43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogoh</surname><given-names>S</given-names></name></person-group><person-group person-group-type="author"><name><surname>Ainslie</surname><given-names>PN</given-names></name></person-group><article-title>Cerebral blood flow during exercise: mechanisms of regulation</article-title><source>J. Appl. Physiol</source><year>2009</year><volume>107</volume><fpage>1370</fpage><lpage>1380</lpage><pub-id pub-id-type="pmid">19729591</pub-id></element-citation></ref><ref id="b44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okazawa</surname><given-names>H</given-names></name><name><surname>Yamauchi</surname><given-names>H</given-names></name><name><surname>Sugimoto</surname><given-names>K</given-names></name><name><surname>Toyoda</surname><given-names>H</given-names></name><name><surname>Kishibe</surname><given-names>Y</given-names></name></person-group><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>M</given-names></name></person-group><article-title>Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers</article-title><source>J. Cereb. Blood Flow Metab</source><year>2001</year><volume>21</volume><fpage>1472</fpage><lpage>1479</lpage><pub-id pub-id-type="pmid">11740209</pub-id></element-citation></ref><ref id="b45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinna</surname><given-names>GD</given-names></name><name><surname>Maestri</surname><given-names>R</given-names></name><name><surname>Mortara</surname><given-names>A</given-names></name></person-group><person-group person-group-type="author"><name><surname>La Rovere</surname><given-names>MT</given-names></name></person-group><article-title>Cardiorespiratory interactions during periodic breathing in awake chronic heart failure patients</article-title><source>Am. J. Physiol. Heart Circ. Physiol</source><year>2000</year><volume>278</volume><fpage>H932</fpage><lpage>H941</lpage><pub-id pub-id-type="pmid">10710362</pub-id></element-citation></ref><ref id="b46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Chua</surname><given-names>TP</given-names></name><name><surname>Francis</surname><given-names>D</given-names></name><name><surname>Banasiak</surname><given-names>W</given-names></name><name><surname>Poole-Wilson</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: clinical implications and role of augmented peripheral chemosensitivity</article-title><source>Circulation</source><year>1999</year><volume>100</volume><fpage>2418</fpage><lpage>2424</lpage><pub-id pub-id-type="pmid">10595954</pub-id></element-citation></ref><ref id="b47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Read</surname><given-names>DJ</given-names></name></person-group><article-title>A clinical method for assessing the ventilatory response to carbon dioxide</article-title><source>Australas Ann. Med</source><year>1967</year><volume>16</volume><fpage>20</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">6032026</pub-id></element-citation></ref><ref id="b48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richalet</surname><given-names>J-P</given-names></name><name><surname>Rivera</surname><given-names>M</given-names></name><name><surname>Bouchet</surname><given-names>P</given-names></name><name><surname>Chirinos</surname><given-names>E</given-names></name><name><surname>Onnen</surname><given-names>I</given-names></name><name><surname>Petitjean</surname><given-names>O</given-names></name><etal/></person-group><article-title>Acetazolamide: a treatment for chronic mountain sickness</article-title><source>Am. J. Respir. Crit. Care Med</source><year>2005</year><volume>172</volume><fpage>1427</fpage><lpage>1433</lpage><pub-id pub-id-type="pmid">16126936</pub-id></element-citation></ref><ref id="b49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richalet</surname><given-names>J-P</given-names></name><name><surname>Larmignat</surname><given-names>P</given-names></name><name><surname>Poitrine</surname><given-names>E</given-names></name><name><surname>Letournel</surname><given-names>M</given-names></name></person-group><person-group person-group-type="author"><name><surname>Canou&#x000ef;-Poitrine</surname><given-names>F</given-names></name></person-group><article-title>Physiological risk factors for severe high-altitude illness: a prospective cohort study</article-title><source>Am. J. Respir. Crit. Care Med</source><year>2012</year><volume>185</volume><fpage>192</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">22071330</pub-id></element-citation></ref><ref id="b50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>R</given-names></name><name><surname>Lonsdorfer-Wolf</surname><given-names>E</given-names></name><name><surname>Charloux</surname><given-names>A</given-names></name><name><surname>Doutreleau</surname><given-names>S</given-names></name><name><surname>Buchheit</surname><given-names>M</given-names></name><name><surname>Oswald-Mammosser</surname><given-names>M</given-names></name><etal/></person-group><article-title>Non-invasive cardiac output evaluation during a maximal progressive exercise test, using a new impedance cardiograph device</article-title><source>Eur. J. Appl. Physiol</source><year>2001</year><volume>85</volume><fpage>202</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">11560071</pub-id></element-citation></ref><ref id="b51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Ch</surname><given-names>M</given-names></name><name><surname>Huicho</surname><given-names>L</given-names></name><name><surname>Bouchet</surname><given-names>P</given-names></name><name><surname>Richalet</surname><given-names>JP</given-names></name></person-group><person-group person-group-type="author"><name><surname>Le&#x000f3;n-Velarde</surname><given-names>F</given-names></name></person-group><article-title>Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness</article-title><source>Respir. Physiol. Neurobiol</source><year>2008</year><volume>162</volume><fpage>184</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">18603026</pub-id></element-citation></ref><ref id="b52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinski</surname><given-names>M</given-names></name><name><surname>Lewandowski</surname><given-names>J</given-names></name><name><surname>Przybylski</surname><given-names>J</given-names></name><name><surname>Zalewski</surname><given-names>P</given-names></name><name><surname>Symonides</surname><given-names>B</given-names></name><name><surname>Abramczyk</surname><given-names>P</given-names></name><etal/></person-group><article-title>Deactivation of carotid body chemoreceptors by hyperoxia decreases blood pressure in hypertensive patients</article-title><source>Hypertens. Res</source><year>2014</year><volume>37</volume><fpage>858</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">24804611</pub-id></element-citation></ref><ref id="b53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skow</surname><given-names>RJ</given-names></name><name><surname>Tymko</surname><given-names>MM</given-names></name><name><surname>MacKay</surname><given-names>CM</given-names></name><name><surname>Steinback</surname><given-names>CD</given-names></name></person-group><person-group person-group-type="author"><name><surname>Day</surname><given-names>TA</given-names></name></person-group><article-title>The effects of head-up and head-down tilt on central respiratory chemoreflex loop gain tested by hyperoxic rebreathing</article-title><source>Prog. Brain Res</source><year>2014</year><volume>212</volume><fpage>149</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">25194198</pub-id></element-citation></ref><ref id="b54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solin</surname><given-names>P</given-names></name><name><surname>Roebuck</surname><given-names>T</given-names></name><name><surname>Johns</surname><given-names>DP</given-names></name><name><surname>Walters</surname><given-names>EH</given-names></name></person-group><person-group person-group-type="author"><name><surname>Naughton</surname><given-names>MT</given-names></name></person-group><article-title>Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure</article-title><source>Am. J. Respir. Crit. Care Med</source><year>2000</year><volume>162</volume><fpage>2194</fpage><lpage>2200</lpage><pub-id pub-id-type="pmid">11112137</pub-id></element-citation></ref><ref id="b55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swenson</surname><given-names>ER</given-names></name></person-group><article-title>Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression</article-title><source>Eur. Respir. J</source><year>1998</year><volume>12</volume><fpage>1242</fpage><lpage>1247</lpage><pub-id pub-id-type="pmid">9877470</pub-id></element-citation></ref><ref id="b56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swenson</surname><given-names>ER</given-names></name><name><surname>Leatham</surname><given-names>KL</given-names></name><name><surname>Roach</surname><given-names>RC</given-names></name><name><surname>Schoene</surname><given-names>RB</given-names></name><name><surname>Hackett</surname><given-names>WJ</given-names><suffix>Jr</suffix></name><name><surname>Mills</surname><given-names>PH</given-names></name></person-group><article-title>Renal carbonic anhydrase inhibition reduces high altitude sleep periodic breathing</article-title><source>Respir. Physiol</source><year>1991</year><volume>86</volume><fpage>333</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">1788493</pub-id></element-citation></ref><ref id="b57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teppema</surname><given-names>LJ</given-names></name></person-group><article-title>Multifaceted clinical effects of acetazolamide: will the underlying mechanisms please stand up?</article-title><source>J. Appl. Physiol</source><year>2014</year><volume>116</volume><fpage>713</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">24557795</pub-id></element-citation></ref><ref id="b58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vovk</surname><given-names>A</given-names></name><name><surname>Duffin</surname><given-names>J</given-names></name><name><surname>Kowalchuk</surname><given-names>JM</given-names></name><name><surname>Paterson</surname><given-names>DH</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>DA</given-names></name></person-group><article-title>Changes in chemoreflex characteristics following acute carbonic anhydrase inhibition in humans at rest</article-title><source>Exp. Physiol</source><year>2000</year><volume>85</volume><fpage>847</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">11187979</pub-id></element-citation></ref><ref id="b59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waggener</surname><given-names>TB</given-names></name><name><surname>Brusil</surname><given-names>PJ</given-names></name><name><surname>Kronauer</surname><given-names>RE</given-names></name><name><surname>Gabel</surname><given-names>RA</given-names></name></person-group><person-group person-group-type="author"><name><surname>Inbar</surname><given-names>GF</given-names></name></person-group><article-title>Strength and cycle time of high-altitude ventilatory patterns in unacclimatized humans</article-title><source>J. Appl. Physiol</source><year>1984</year><volume>56</volume><fpage>576</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">6706767</pub-id></element-citation></ref><ref id="b60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>DP</given-names></name></person-group><article-title>Pathogenesis of Obstructive and Central Sleep Apnea</article-title><source>Am. J. Respir. Crit. Care Med</source><year>2005</year><volume>172</volume><fpage>1363</fpage><lpage>1370</lpage><pub-id pub-id-type="pmid">16100008</pub-id></element-citation></ref><ref id="b61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Younes</surname><given-names>M</given-names></name><name><surname>Ostrowski</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>W</given-names></name><name><surname>Leslie</surname><given-names>C</given-names></name></person-group><person-group person-group-type="author"><name><surname>Shewchuk</surname><given-names>W</given-names></name></person-group><article-title>Chemical control stability in patients with obstructive sleep apnea</article-title><source>Am. J. Respir. Crit. Care Med</source><year>2001</year><volume>163</volume><fpage>1181</fpage><lpage>1190</lpage><pub-id pub-id-type="pmid">11316657</pub-id></element-citation></ref></ref-list></back></article>